Podcasts about cochrane database

Identifying and Evaluating Young Children with Developmental Central Hypotonia: An Overview of Systematic Reviews and ToolsChildren with developmental central hypotonia have reduced muscle tone secondary to non-progressive damage to the brain or brainstem. Children may have transient delays, mild or global functional impairments, and the lack of a clear understanding of this diagnosis makes evaluating appropriate interventions challenging. This overview aimed to systematically describe the best available evidence for tools to identify and evaluate children with developmental central hypotonia aged 2 months to 6 years. A systematic review of systematic reviews or syntheses was conducted with electronic searches in PubMed, Medline, CINAHL, Scopus, Cochrane Database of Systematic Reviews, Google Scholar, and PEDro and supplemented with hand-searching. Methodological quality and risk-of-bias were evaluated, and included reviews and tools were compared and contrasted. Three systematic reviews, an evidence-based clinical assessment algorithm, three measurement protocols, and two additional measurement tools were identified. For children aged 2 months to 2 years, the Hammersmith Infant Neurological Examination has the strongest measurement properties and contains a subset of items that may be useful for quantifying the severity of hypotonia. For children aged 2-6 years, a clinical algorithm and individual tools provide guidance. Further research is required to develop and validate all evaluative tools for children with developmental central hypotonia.

Dr. Feroze Sidhwa discusses Gaza with Clint Borgen. Dr. Sidhaw is a Trauma Surgeon, based in California, with experience in Gaza, Ukraine, the West Bank, Zimbabwe, Haiti, Dominican Republic, and Burkina Faso. He received his Masters in Public Health from Harvard and his Medical Degree from the University of Texas Medical School.Take Action: Urge Congress to meet with American doctors who served in Gaza.Mentioned: Read the letter U.S. doctors sent to Congress.Official podcast of The Borgen Project, an international organization that works at the political level to improve living conditions for people impacted by war, famine and poverty.borgenproject.orgGuest BioDr. Feroze Sidhwa is a general, trauma, and critical care surgeon in California. He is triple-board certified in general surgery, trauma/surgical critical care, and neurocritical care, and is a Fellow of the American College of Surgeons and of the International College of Surgeons.Feroze is also a humanitarian surgeon. He has worked most extensively in Palestine, but has also worked in Ukraine three times with the International Medical Corps and Harvard Humanitarian Initiative, and in Zimbabwe, Haiti, Dominican Republic, and Burkina Faso. He has helped edit books on the Israeli-Palestinian conflict published by University of California Press (Berkeley, CA), O/R Books (London, UK), and the Institute for Palestine Studies (Washington, DC). He is widely published in the medical literature, including in The Journal of the American College of Surgeons, Annals of Surgery, World Journal of Surgery, Journal of Bone and Joint Surgery, Cochrane Database of Systematic Reviews, Surgical Infections, Plastic and Reconstructive Surgery, JAMA Pediatrics, Journal of Pediatric Surgery, and Journal of Laproendoscopic and Advanced Surgical Techniques, among others. Feroze has spoken on humanitarian relief work and its political implications at the Harvard FXB Center for Health and Human Rights, the University of California San Francisco School of Medicine, as the keynote speaker of the Stanford 31st Annual Trauma Critical Care Symposium, at UChicago Medicine Trauma Grand Rounds, at the University of Chicago Pritzker School of Medicine, University of Chicago Law School, Johns Hopkins University and School of Public Health, Johns Hopkins School of Advanced International Studies, MIT, Kings County Hospital in Brooklyn, SUNY Downstate College of Medicine, NYU, the Hawaii Medical Association, and the University of Hawaii A. John Burns School of Medicine. He has also spoken widely in the community, mostly in the San Francisco Bay Area but also with Jewish Voice for Peace Phoenix and Tucson, Massachusetts Peace Action, the 2024 Democratic National Convention, and elsewhere.Lay publications about Feroze's humanitarian surgical work and its political implications include:New York Times, October 9, 2024. “65 Doctors, Nurses and Paramedics: What We Saw in Gaza”Haaretz (Israel), October 17, 2024. “65 אנשי רפואה לניו יורק טיימס: אלה המחזות שראינו בעזה”Politico, July 19, 2024. “We Volunteered at a Gaza Hospital. What We Saw Was Unspeakable.”CommonDreams.org, May 23, 2024. “The Atlantic's Sloppy Reporting on UN Gaza Statistics Jeopardizes Its Credibility”CommonDreams.org, April 11, 2024. “As Surgeons, We Have Never Seen Cruelty Like Israel's Genocide in Gaza”Columbia Daily Spectator, January 29, 2025. “In Gaza, a ‘political' ethical problem is still an ethical problem.”Feroze is the primary author of two open letters to the Biden-Harris administration regarding the United States' role in the Israeli assault on Gaza that followed the October 7, 2023 attacks on Israel, as well as the appendices accompanying those letters. These letters were updated and sent to the Trump transition team on November 15, 2024.Feroze has appeared on CNN's Amanpour, PBS, MSNBC's Ayman Mohyeldin Reports, Democracy Now!, CNN international, the Australia Broadcasting Corporation, DropSite News, NPR, and the BBC World News, as well as a variety of radio programs and podcasts. He has been quoted widely in mainstream and alternative media, including on CBS Sunday Morning News, ABC News, Reuters, the Washington Post, Mother Jones, the New Republic, Mainchi Newspaper (Japan), Local Call (Israel), the Huffington Post, the New Statesman, NRK (Norway), the Guardian, the Independent, Pass Blue, and Democracy Now! Dr. Sidhwa serves as a peer reviewer for the Journal of the American College of Surgeons on global surgical topics and as an external expert reviewer for Human Rights Watch.Feroze was born in Houston, TX to Parsi parents who left Pakistan to find a better life. They moved to the UK and then in the United States. Feroze grew up in Flint, MI. After graduating from Johns Hopkins University in 2004 with a bachelor's degree in public health he lived in Haifa, Israel for one year, working with a Palestinian-Jewish cooperative in the city. He then taught middle school in east Baltimore for one year before starting medical school at the University of Texas School of Medicine at San Antonio. During his time in medical school he also obtained a Master of Public Health from the Harvard School of Public Health.After finishing medical school, Feroze joined the general surgery residency program at Boston Medical Center. During his residency he completed a surgical research fellowship at Boston Children's Hospital. During that time Feroze treated victims of the Boston Marathon Bombing. After finishing residency in 2018 he began his one-year trauma/surgical critical care fellowship at Cooper University Healthcare in Camden, NJ. After completing his fellowship, he moved to California where he now practices as a trauma surgeon at a county hospital and as a general surgeon in the Veterans Affairs Northern California Health Care System.Dr. Sidhwa critiques the United States' role in the Israeli-Palestinian conflict through a unique lens. He is a secular American with no ethnic or religious ties to the Middle East. He has a broad knowledge of Israeli and American academic work on the conflict, and closely follows the technical humanitarian, human rights, medical, political, economic, and environmental research done on the topic by Israeli, Palestinian, and international agencies. His public health degrees afford him a broad understanding of how these different areas affect the people of the region. He has no interest in any particular political solution to the conflict. And, most importantly to him, he has seen the conflict in person, seen what it is doing to Palestinians and to Israelis, and has treated its victims with his own hands.

¿Es el Omega 3 una estafa? En este video te explico por qué la mayoría de suplementos de omega 3 NO FUNCIONAN, qué tipos existen, cuál es inútil, y cómo elegir un suplemento que de verdad sirva. También te muestro cómo conseguir omega 3 de forma natural y qué señales indican que tu suplemento puede estar oxidado y ser peligroso. Una guía completa, basada en ciencia, que necesitas ver antes de seguir tomando nada.✔️ Qué es el omega 3 y por qué es esencial✔️ El error común de confiar en el ALA✔️ Cómo evitar suplementos oxidados que pueden dañar tu salud✔️ Las dosis reales que funcionan según la ciencia✔️ Alimentos que sí aportan EPA y DHA de forma natural

The Snowflake FairyRobed in white comes Snowflake Fairy,braving wintry winds and ice,pearly "Maid of February,"whom the glistening frosts entice.Gladly welcome Snowflake Fairy,on your terrace give her room.She alone in Februarybraves the cold to shed her bloom.—Elizabeth GordonMusic by James Milor from PixabayInformation provided by:Flowers and Their Meanings: The Secret Language and History of Over 600 Blooms by Karen Azoulay (2023)https://www.bloomandwild.com/the-blog/snowdrop-flowers-meaninghttps://www.chicagobotanic.org/plantinfo/plant_profiles/snowdropsPlants That Kill: A Natural History of the World's Most Poisonous Plants by Elizabeth A. Dauncey and Sonny Larson (2018)Galanthus trojanus: a new species of Galanthus (Amaryllidaceae) from north-western Turkey by Aaron P. Davis and Neriman Ozhatay (2001). Botanical Journal of the Linnean Society, 137, pg. 409-412. DOI: 10.1006/boj1.2001.048.Peterson Field Guide to Medicinal Plants and Herbs of Eastern and Central North America (3rd ed.) by Steven Foster and James A. Duke (2014)https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:77118772-1/general-informationGalantamine for Alzheimer's disease and mild cognitive impairment by Clement Loy and Lon Schneider (2006). Cochrane Database of Systematic Reviews, 1. https://doi.org/10.1002/14651858.CD001747.pub3https://plants.ces.ncsu.edu/plants/galanthus-nivalis/Homer's Moly identified as Galanthus nivalis L.: Physiologic antidote to stramonium poisoning by Andreas Plaitakis and Roger C. Duvoisin (1983). Clinical Neuropharmacology, 6(1), pg. 1-6. [Abstract]. Collins Gem: Wild Flowers by Martin Walter (2002)https://en.m.wikipedia.org/wiki/Galanthushttps://www.woodlandtrust.org.uk/trees-woods-and-wildlife/plants/wild-flowers/snowdrop/

En lo último en salud y fitness edición de febrero 2025, damos un paseo por las últimas tendencias, investigaciones y noticias en el mundo de la salud y el fitness. Hoy vamos a ver qué dice la ciencia sobre algunos temas que seguro te interesan: desde cómo la genética afecta tus resultados con la creatina, hasta si realmente funciona eso de poner las calorías en los menús de los restaurantes. También veremos si escuchar música mientras tomas café te hace entrenar mejor (spoiler: sí) y qué pasa con tu cuerpo cuando te tomas un descanso del gimnasio. Esta semana nos metemos de lleno con estudios que nos dan respuestas claras y consejos que puedes aplicar ya mismo. Atajos del Episodio 02:21 – ¿Tu genética define cuánto músculo ganas con creatina?1 06:28 – ¿Música y cafeína para rendir mejor? Un dúo explosivo en el entrenamiento2 10:00 – ¿Tomarte un descanso del gym arruina tus ganancias? La ciencia dice que no (tanto)3 12:32 – ¿Los menús con calorías te ayudan a comer menos? La ciencia dice… más o menos4 15:42 – ¿Comer en una ventana de 8 horas realmente mejora tu salud?5   Referencias: 1.      Varillas-Delgado, D. Association of genetic profile with muscle mass gain and muscle injury prevention in professional football players after creatine supplementation. Nutrients (2024). 2.      Qiu, B. et al. Effects of Caffeine Intake Combined with Self-Selected Music During Warm-Up on Anaerobic Performance: A Randomized, Double-Blind, Crossover Study. Nutrients (2025). 3.      Halonen, E. J., Gabriel, I. & Kelahaara…, M. M. Does Taking a Break Matter—Adaptations in Muscle Strength and Size Between Continuous and Periodic Resistance Training. … Journal of Medicine … (2024). 4.      Clarke, N., Pechey, E., Shemilt, I. & Pilling…, M. Calorie (energy) labelling for changing selection and consumption of food or alcohol. Cochrane Database … (2025). 5.      Manoogian, E. N. C., Wilkinson, M. J. & O'Neal…, M. Time-restricted eating in adults with metabolic syndrome: a randomized controlled trial. Annals of Internal … (2024).

Language delays are one of the most common concerns brought up in pediatric well visits. Dr. Jennifer Poon, a pediatric specialist in Development and Behavior, joins Dr. Sarah Straka and medical student Alisha Patel to discuss how to recognize and manage language delays. Specifically, they will: Define and understand language delay. Recognize the initial signs and symptoms of language delays. Identify and explain clinical pearls of potential etiologies of language delays. Recognize the developmental milestones for language based on age. Discuss the prevalence of language delays as well as identify the risk factors and patient demographics that have an increased susceptibility. Understand the initial diagnostic approach to the child with suspected language delay. Review the most common interventions when a child has language delay. Understand how to best discuss the prognosis for language delays and counsel the families and caregivers CME Credit (requires free sign up):   link coming soon! References: Karani NF, Sher J, Mophosho M. The influence of screen time on children's language development: A scoping review. S Afr J Commun Disord. 2022 Feb 9;69(1):e1-e7. doi: 10.4102/sajcd.v69i1.825. PMID: 35144436; PMCID: PMC8905397. Law, James et al. “Speech and language therapy interventions for children with primary speech and/or language disorders.” The Cochrane Database of Systematic Reviews 2017,1 CD012490. 9 Jan. 2017, doi:10.1002/14651858.CD012490 Sices, Laura, and Marilyn Augustyn. “Expressive Language Delay (‘Late Talking') in Young Children.” Edited by Robert G Voigt and Mary Torchia, UptoDate, Wolters Kluwer, UpToDate, Inc., 25 Jan. 2022, https://www.uptodate.com/contents/expressive-language-delay-late-talking-in-young-children. Spratt, Eve G et al. “The Effects of Early Neglect on Cognitive, Language, and Behavioral Functioning in Childhood.” Psychology (Irvine, Calif.) 3,2 (2012): 175-182. doi:10.4236/psych.2012.32026 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652241/ Sunderajan, Trisha, and Sujata V Kanhere. “Speech and language delay in children: Prevalence and risk factors.” Journal of family medicine and primary care 8,5 (2019): 1642-1646. doi:10.4103/jfmpc.jfmpc_162_19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559061/ Takahashi I, Obara T, Ishikuro M, et al. Screen Time at Age 1 Year and Communication and Problem-Solving Developmental Delay at 2 and 4 Years. JAMA Pediatr.Published online August 21, 2023. doi:10.1001/jamapediatrics.2023.3057 Young, Allen. and Matthew Ng. “Genetic Hearing Loss.” StatPearls, StatPearls Publishing, 17 April 2023. https://www.ncbi.nlm.nih.gov/books/NBK580517/ Zuckerman B, Khandekar A. Reach Out and Read: evidence based approach to promoting early child development. Curr Opin Pediatr. 2010 Aug;22(4):539-44. doi: 10.1097/MOP.0b013e32833a4673. PMID: 20601887.

Introducing 4 immunity tips for healthy ageing | Dr. Jenna Macciochi from ZOE Science & Nutrition.Follow the show: ZOE Science & Nutrition Over the last two years, there's been a rise in “immune-boosting” foods, supplements and trends. Today's guest, immunologist Dr. Jenna Macciochi, believes the immune system doesn't need boosting. Instead, it should be balanced.In this episode, Jenna - a Senior Lecturer in Immunology at the University of Sussex - reveals how your immune system is your body's housekeeper. Jenna highlights the case for the ‘good bugs' in our gut microbiome, the role of micronutrients and how our immune system isn't born, but made.We'll also tackle the age-old question: do we really need Vitamin C supplements?

Avec Dr Jean-François Chicoine, pédiatre au CHU Sainte-Justine et professeur agrégé de clinique à l'Université de Montréal, ainsi que Pascal Bédard, pharmacien en pédiatrie générale au CHU Sainte-Justine, nous allons:explorer les options sans ordonnance pour le rhume et la grippe chez les enfants;discuter de la place du salicylate de bismuth, des probiotiques et de certains produits homéopathiques pour les problèmes gastrointestinaux;résumer quelles vitamines seraient appropriées et quels produits pour la douleur et le confort sont à privilégier.Merci beaucoup de prendre 2 minutes pour le sondage afin d'encourager le balado! Disponible ici ✨ (ouvert jusqu'au 19.01.2025)Références:CHU Sainte-Justine: ORL. L'hygiène nasale. 2024 et dépliant d'information: L'hygiène nasale.Smith SM et al. Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database of Systematic Reviews 2014Paul IM et al. Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. Arch Pediatr Adolesc Med. 2007 Santé Canada. Norme d'étiquetage des médicaments pédiatriques en vente libre contre la toux et le rhume administrés par voie orale. 2009.Tang SC et al. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians. Pediatr Res. 2022 Green JL et al. Safety Profile of Cough and Cold Medication Use in Pediatrics. Pediatrics. 2017Goldman RD. Bismuth salicylate for diarrhea in children. Can Fam Physician. 2013Santé Canada. Information sur les produits homéopathiques et Preuves relatives aux médicaments homéopathiques. 2022National Center for Complementary and Integrative Health. Homeopathy: What You Need To Know. 2021Société canadienne de pédiatrie. La prévention de la carence en vitamine D symptomatique et du rachitisme chez les nourrissons et les enfants autochtones du Canada. 2022 Santé Canada. Aliments enrichis : Approche du Canada en matière d'enrichissement. 2024Merci pour l'écoute! Allez mettre une réaction sur vos épisodes préférés, partagez la bonne nouvelle sur Facebook/Instagram et abonnez-vous pour ne rien manquer

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychotherapy in youth with Dr. Laurence Katz, a professor of child and adolescent psychiatry at the University of Manitoba. Dr. Katz received his medical and adult psychiatric training at the University of Manitoba and his child and adolescent psychiatry training at the Albert Einstein College of Medicine, Bronx N.Y. He is an adjunct scientist at the Manitoba Centre for Health Policy and has published numerous papers using the population health administrative database in mental health outcomes. He has held and been part of numerous grants funded by CIHR, PHAC, and other national funding agencies related to work with First Nations communities. Dr. Katz is widely published in particular in the areas of suicide and suicidal behaviour. His other research interests include Dialectical Behaviour Therapy, pharmacoepidemiology, and implementation of complex interventions. The learning objectives for this episode are as follows: By the end of this episode, the listener will be able to… Outline which psychotherapeutic modalities are commonly used in youth Identify which youth may benefit/should be referred for psychotherapy Discuss important considerations in delivering psychotherapy to youth Guest: Dr. Laurence Katz Hosts: Wendy MacMillan-Wang, Shaoyuan Wang, Kate Braithwaite, and Sara Abrahamson Audio editing by: Angad Singh Show notes by: Kate Braithwaite Interview content: Introduction - 0:04 Guest introduction - 00:44 Learning objectives - 05:25 Definitions - 06:00 Types of psychotherapy in youth - 07:44 Evolution of psychotherapy in youth over time - 13:10 Psychotherapy in suicide prevention/risk mitigation - 16:24 Challenges in research: decrease in effect sizes over time - 18:32 Conditions responding best to psychotherapy - 22:01 Youth specific modalities - 26:44 Summary of learning objective 1 - 29:49 Indications and contraindications - 30:23 Consent - 37:31 Group therapy - 39:31 Summary of learning objective 2 - 46:27 Differences in psychotherapy in youth compared to adults in practice - 47:10 Techniques for engagement of youth - 53:32 Family involvement - 58:21 Confidentiality - 1:02:39 Use of mobile apps/internet-based therapies - 1:07:20 Summary of learning objective 3 - 1:11:17 Other considerations - 1:12:35 End credits - 1:16:52 References: Agostino, H., & Toulany, A. (2023). Considerations for privacy and confidentiality in adolescent health care service delivery. Paediatrics & Child Health, 28(3), 172–183. https://doi.org/10.1093/pch/pxac117 American Academy of Child and Adolescent Psychiatry. (2019, April). Psychotherapies for children and adolescents: different types. Facts for Families Guide. Retrieved from https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Psychotherapies-For-Children-And-Adolescents-086.aspx Bailin, A., Cho, E., Sternberg, A., & others. (2023). Principle-guided psychotherapy for children and adolescents (FIRST): Study protocol for a randomized controlled effectiveness trial in outpatient clinics. Trials, 24, Article 682. https://doi.org/10.1186/s13063-023-07717-y Bhide, A., & Chakraborty, K. (2020). General principles for psychotherapeutic interventions in children and adolescents. Indian Journal of Psychiatry, 62(Suppl 2), S299–S318. CADDRA - Canadian ADHD Resource Alliance. (2020). Canadian ADHD practice guidelines (4.1 ed.). Toronto, ON: CADDRA. Christner, R. W., Stewart, J. L., & Mulligan, C. A. (Eds.). (2024). Handbook of cognitive-behavior group therapy with children and adolescents: Specific settings and presenting problems (2nd ed.). Routledge. Campisi, S. C., Ataullahjan, A., Baxter, J. B., Szatmari, P., & Bhutta, Z. A. (2022). Mental health interventions in adolescence. Current Opinion in Psychology, 48. https://doi.org/10.1016/j.copsyc.2022.101492 Katzman, M. A., Bleau, P., Blier, P., & others. (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress, and obsessive-compulsive disorders. BMC Psychiatry, 14(Suppl 1), S1. https://doi.org/10.1186/1471-244X-14-S1-S1 Kendall, P. C., Ney, J. S., Maxwell, C. A., Lehrbach, K. R., Jakubovic, R. J., McKnight, D. S., & Friedman, A. L. (2023). Adapting CBT for youth anxiety: Flexibility within fidelity in different settings. Frontiers in Psychiatry, 14, Article 1067047. https://doi.org/10.3389/fpsyt.2023.1067047 Kernberg, P. F., Ritvo, R., Keable, H., & American Academy of Child an Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) (2012). Practice Parameter for psychodynamic psychotherapy with children. Journal of the American Academy of Child and Adolescent Psychiatry, 51(5), 541–557. https://doi.org/10.1016/j.jaac.2012.02.015 Lam, R. W., Kennedy, S. H., Adams, C., & others. (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry, 69(9), 641–687. https://doi.org/10.1177/07067437241245384 Oetzel, K. B., & Scherer, D. G. (2003). Therapeutic engagement with adolescents in psychotherapy. Psychotherapy: Theory, Research, Practice, Training, 40(3), 215–225. https://doi.org/10.1037/0033-3204.40.3.215 Wergeland, G. J., Fjermestad, K. W., Marin, C. E., Haugland, B. S., Bjaastad, J. F., Oeding, K., Bjelland, I., Silverman, W. K., Öst, L. G., Havik, Ø. E., & Heiervang, E. R. (2014). An effectiveness study of individual versus group cognitive behavioral therapy for anxiety disorders in youth. Behaviour Research and Therapy, 57, 1–12. https://doi.org/10.1016/j.brat.2014.03.007 Witt, K. G., Hetrick, S. E., Rajaram, G., Hazell, P., Taylor Salisbury, T. L., Townsend, E., & Hawton, K. (2021). Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews, 3, Article CD013667. https://doi.org/10.1002/14651858.CD013667.pub2 Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O'Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., McIntyre, R. S., Kozicky, J., Kanba, S., Lafer, B., Suppes, T., Calabrese, J. R., Vieta, E., Malhi, G., Post, R. M., & Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609 For more PsychEd, follow us on Instagram (@psyched.podcast), X (@psychedpodcast), and Facebook (PsychEd Podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

The Flu Vaccine: Science at its Worst   Richard Gale and Gary Null Progressive Radio Network, December 20, 2024   Joshua Hadfield was a normal, healthy developing child as a toddler. In the midst of the H1N1 swine flu frenzy and the media fear mongering about the horrible consequences children face if left unvaccinated, the Hadfield family had Joshua vaccinated with Glaxo's Pandermrix influenza vaccine.  Within weeks, Joshua could barely wake up, sleeping up to nineteen hours a day. Laughter would trigger seizures. Joshua was diagnosed with narcolepsy, “an incurable, debilitating condition” associated with acute brain damage.[1]  Looking back, Pandermrix was a horrible vaccine.  Research indicates that it was associated with a 1400% increase in narcolepsy risk. A medical team at Finland's National Institute for Health and Welfare recorded 800 cases of narcolepsy associated with this vaccine.  Aside from the engineered viral antigens, the other vaccine ingredients are most often found to be the primary culprits to adverse vaccine reactions. The Finnish research, on the other hand, indicated that the vaccine's altered viral nucleotide likely contributed to the sudden rise in sleeping sickness.[2] Although Pandermrix was pulled from the market for its association with narcolepsy and cataplexy (sudden muscle weakness), particularly in children, it should never have been approved and released in the first place.  The regulatory fast tracking of the HINI flu vaccines is a classic, and now common, example of regulatory negligence by nations' health officials. The failure of proper regulatory evaluation and oversight resulted in Joshua and over 1,000 other people becoming disabled for life. Settlements to cover lawsuits exceeded 63 million pounds in the UK alone.  No one should feel complacent and assume flu vaccine risks only affect young children. Sarah Behie was 20 years old after receiving a flu shot.  Three weeks later her health deteriorated dramatically. Diagnosed with Guillain-Barre syndrome, a not uncommon adverse effect of influenza vaccination, four years later Sarah remains paralyzed from the waist down, incapable of dressing and feeding herself, and rotting away in hospitals and nursing homes.[3]  Flu vaccines are perhaps the most ineffective vaccine on the market.  Repeatedly we are told by health officials that the moral argument for its continued use is for “the greater good,” although this imaginary good has never been defined scientifically. Year to year, how effective any given seasonal flu vaccine will be is a throw of the dice. Annual flu vaccine efficacy rates in the US have demonstrated significant variability. Data from the CDC reveal efficacy estimates of approximately 39% for the 2020–2021 season, 37% for 2021–2022, 52% for 2022–2023, and a preliminary estimate of 50% for the 2023–2024 season.  Preliminary CDC estimates for this flu season estimates 34% likely efficacy. Although these are CDC's figures, independent figures are consistently much lower. At their best, flu vaccines in recent years are around 50% effective according to official health analysis. During some seasons, vaccine efficacy is a bust. For example, the 2014-2015 flu season strain match was such a failure that the CDC warned the American public that the vaccine was only 23% effective.[4]  Nevertheless, these rates underscore the vaccine's inconsistent protection. Studies such as those by Skowronski and Belongia further highlight flu vaccines' variability and force to question whether the vaccine is capable of providing any reliable protection.[5,6] Moreover, Cochrane Collaboration reviews, known for their rigorous analyses, consistently find that flu vaccines reduce influenza-like illness by only about 1% in healthy adults and have negligible impact on hospitalizations and mortality rates. This limited efficacy raises critical concerns about the vaccine's utility, particularly when weighed against its risks.  Perhaps the most useless flu vaccine that should have never been approved was Medimmune's live attenuated flu vaccine (LAIV) FluMist, which the CDC later had removed from the market because it was found to so ineffective—only 3 percent according to an NBC report.[6] However the real reason may be more dire, and this a fundamental problem of all live and attenuated vaccines: these vaccines have been shown to “shed” and infect people in contact with the vaccinated persons, especially those with compromised immune systems.  Consequently, both the unvaccinated and the vaccinated are at risk.  The CDC acknowledges this risk and warns “Persons who care for severely immunosuppressed persons who require a protective environment should not receive LAIV, or should avoid contact with such persons for 7 days after receipt, given the theoretical risk for transmission of the live attenuated vaccine virus.”[7]  According to the FDA's literature on FluMist, the vaccine was not studied for immunocompromised individuals (yet was still administered to them), and has been associated with acute allergic reactions, asthma, Guillain-Barre, and a high rate of hospitalizations among children under 24 months – largely due to upper respiratory tract infections.  Other adverse effects include pericarditis, congenital and genetic disorders, mitochondrial encephalomyopathy or Leigh Syndrome, meningitis, and others.[8]  The development and promotion of the influenza vaccine was never completely about protecting the public. It has been the least popular vaccine in the US, including among healthcare workers. Rather, similar to the mumps vaccine in the MMR, it has been the cash cow for vaccine makers.  Determining the actual severity of any given flu season is burdened by federal intentional confusion to mislead the public.  The CDC's first line of propaganda defense to enforce flu vaccinations is to exaggerate flu infections as the cause of preventable deaths.   However, validating this claim is near impossible because the CDC does not differentiate deaths caused by influenza infection and deaths due to pneumonia.  On its website, the CDC lumps flu and pneumonia deaths together, currently estimated at 51,000 per year. The large majority of these were pneumonia deaths of elderly patients. Yet in any given year, only 3-18% of suspected influenza infections actually test positive for a Type A or B influenza strain.[9]  As an aside, it is worth noting that during the first two years of the COVID-19 pandemic, an extraordinary and unprecedented phenomenon occurred: influenza infections, which have long been a seasonal health challenge, seemingly disappeared. Federal health agencies such as the CDC attributed this sharp decline in flu cases to the implementation of non-pharmaceutical interventions (NPIs) like mask-wearing, social distancing, and widespread lockdowns. However, this explanation raises critical questions about its plausibility. If these measures were effective enough to virtually eliminate influenza, why did they not similarly prevent the widespread transmission of SARS-CoV-2? This contradiction highlights the need to critically examine the possible explanations behind the anomaly, questioning whether the disappearance of the flu was truly a result of public health measures or due to other factors such as diagnostic practices, viral interference, and disruptions to seasonal flu patterns. If these interventions were indeed effective, their impact should not have been so starkly selective between two similarly transmitted viruses. This contradiction undermines the plausibility of attributing the disappearance of flu cases solely to NPIs. A more plausible explanation for the disappearance of flu cases lies in the diagnostic focus on SARS-CoV-2 during the pandemic. Individuals presenting with flu-like symptoms were overwhelmingly diagnosed for COVID-19 with faulty PCR testing methods rather than influenza, as public health resources were directed toward managing the pandemic. This prioritization inevitably led to a significant underreporting of flu cases. Furthermore, the symptoms of influenza and COVID-19 overlap significantly, including fever, cough, and fatigue. In the absence of influenza testing, many flu cases were wrongly diagnosed as COVID-19, further inflating SARS-CoV-2 case numbers while contributing to the perceived disappearance of the flu.  One of the more controversial findings in recent flu vaccine research involves the phenomenon of viral interference, wherein vaccinated individuals may become more susceptible to other respiratory pathogens. To date there is only one gold standard clinical trial with the flu vaccine that compares vaccinated vs. unvaccinated, and it is not good news for the CDC, the vaccine makers, and the push to booster everyone with the Covid-19 mRNA vaccines. This Hong Kong funded double-blind placebo controlled study followed the health conditions of vaccinated and unvaccinated children between the ages of 6-15 years for 272 days. The trial concluded the flu vaccine holds no health benefits. In fact, those vaccinated with the flu virus were observed to have a 550% higher risk of contracting non-flu virus respiratory infections. Among the vaccinated children, there were 116 flu cases compared to 88 among the unvaccinated; there were 487 other non-influenza virus infections, including coronavirus, rhinovirus, coxsackie, and others, among the vaccinated versus 88 with the unvaccinated.[10]  This single study alone poses a scientifically sound warning and rationale to avoid flu vaccines at all costs. It raises a further question: how many Covid-19 cases could be directly attributed to weakened immune systems because of prior flu vaccination? A 2019 study conducted by the US Armed Forces investigated the relationship between influenza vaccination and susceptibility to other respiratory infections, including coronaviruses. Analyzing data from over 9,000 individuals, the researchers found that people who received the flu vaccine were more likely to test positive for certain non-influenza respiratory viruses. Notably, influenza vaccination was associated with an increased likelihood of contracting coronaviruses and human metapneumovirus.[11] These findings suggest a complex interaction between influenza vaccination and susceptibility to different respiratory pathogens, and challenges the belief that flu vaccines provide greater benefits over risks. The same researchers' follow up study in in 2020 furthermore concluded that “vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus.[12] Additional recent studies, such as those by Bodewes, which identified immune interference due to repeated annual flu vaccinations,[13] and Shinjoh, which highlighted increased viral interference in vaccinated children, provide further evidence of this relationship.[14] These findings challenge the prevailing assumption that flu vaccination has only positive effects on immune health and raise important questions about the broader implications of repeated annual vaccination. In a follow up study after the H1N1 swine flu scare, Canadian researcher Dr. Danuta Skowronski noted that individuals with a history of receiving consecutive seasonal flu shots over several years had an increased risk of becoming infected with H1N1 swine flu.  Skowronski commented on the findings, “policy makers have not yet had a chance to fully digest them [the study's conclusions] or understand the implications.”  He continued, “Who knows, frankly? The wise man knows he knows nothing when it comes to influenza, so you always have to be cautious in speculating.”[15] There is strong evidence suggesting that all vaccine clinical trials carried out by manufacturers fall short of demonstrating vaccine efficacy accurately. And when they are shown to be efficacious, it is frequently in the short term and offer only partial or temporary protection. According to an article in the peer-reviewed Journal of Infectious Diseases, the only way to evaluate vaccines is to scrutinize the epidemiological data obtained from real-life conditions. In other words, researchers simply cannot -- or will not -- adequately test a vaccine's effectiveness and immunogenicity prior to its release onto an unsuspecting public.[16] According to Dr. Tom Jefferson, who formerly led the Cochrane Collaboration's vaccine analyses, it makes little sense to keep vaccinating against seasonal influenza based on the evidence.[17] Jefferson has also endorsed more cost-effective and scientifically-proven means of minimizing the transmission of flu, including regular hand washing and wearing masks. There is also substantial peer-reviewed literature supporting the supplementation of Vitamin D.  Dr. Jefferson's conclusions are backed by former Johns Hopkins University School of Medicine scientist Peter Doshi, PhD, in the British Journal of Medicine. In his article Doshi questions the flu vaccine paradigm stating:  “Closer examination of influenza vaccine policies shows that although proponents employ the rhetoric of science, the studies underlying the policy are often of low quality, and do not substantiate officials' claims. The vaccine might be less beneficial and less safe than has been claimed, and the threat of influenza appears overstated.”[18]         A significant body of research proves that receiving the flu shot does not reduce mortality among seniors.[19] One particularly compelling study was carried out by scientists at the federal National Institutes of Health (NIH) and published in the Journal of the American Medical Association (JAMA). Not only did the study indicate that the flu vaccine did nothing to prevent deaths from influenza among seniors, but that flu mortality rates increased as a greater percentage of seniors received the shot.[20] Dr. Sherri Tenpenny reviewed the Cochrane Database reviews on the flu vaccine's efficacy. In a review of 51 studies involving over 294,000 children, there was “no evidence that injecting children 6-24 months of age with a flu shot was any more effective than placebo. In children over 2 years of age, flu vaccine effectiveness was 33 percent of the time preventing flu. In children with asthma, inactivated flu vaccines did not prevent influenza related hospitalizations in children. The database shows that children who received the flu vaccine were at a higher risk of hospitalization than children who did not receive the vaccine.[21]  In a separate study involving 400 asthmatic children receiving a flu vaccine and 400 who were not immunized, there was no difference in the number of clinic and emergency room visits and hospitalizations between the two groups.[22]  In 64 studies involving 66,000 adults, “Vaccination of healthy adults only reduced risk of influenza by 6 percent and reduced the number of missed work days by less than one day. There was a change in the number of hospitalizations compared to the non-vaccinated. In further studies of elderly adults residing in nursing homes over the course of several flu seasons, flu vaccinations were insignificant for preventing infection.[23] Today, the most extreme wing of the pro-vaccine community continue to diligently pursue mandatory vaccination across all 50 states.  During the flu season, the debate over mandatory vaccination becomes most heated as medical facilities and government departments attempt to threaten employees and schools who refuse vaccination. Although this is deeply worrisome to those who advocate their Constitutional rights to freedom of choice in their healthcare, there are respectable groups opposing mandatory flu shots.  The Association of American Physicians and Surgeons “objects strenuously to any coercion of healthcare personnel to receive influenza immunization. It is a fundamental human right not to be subjected to medical interventions without fully informed consent.”  The good news is that the majority of Americans have lost confidence in the CDC after the agency's dismal handling of the Covid-19 pandemic. Positive endorsement of the CDC would plummet further if the public knew the full extent of CDC officials lying to Congress and their conspiracy to commit medical fraud for two decades to cover=up evidence of an autism-vaccine association.  When considering the totality of evidence, the benefit-risk ratio of flu vaccination becomes increasingly problematic. The poor and inconsistent efficacy rates, combined with the potential for serious adverse reactions and the phenomenon of viral interference, clearly indicates that the vaccine does not deliver the public health benefits it promises. Public health strategies must balance the benefits of vaccination against its risks, particularly for vulnerable populations such as children and pregnant women.  Imagine the tens of thousands of children and families who would have been saved from life-long neurological damage and immeasurable suffering if the CDC was not indebted to protecting the pharmaceutical industry's toxic products and was in fact serving Americans' health and well-being? One step that can be taken to begin dismantling the marriage between the federal health agencies and drug companies is to simply refuse the flu vaccine and protect ourselves by adopting a healthier lifestyle during the flu season.    NOTES [1] http://yournewswire.com/boy-awarded-174000-after-flu-vaccine-causes-permanent-brain-damage/  [2]  http://www.globalresearch.ca/finnish-scientists-identify-link-between-glaxosmithklines-swine-flu-vaccine-pandemrix-and-narcolepsy/5423154 [3] http://sharylattkisson.com/woman-paralyzed-after-flu-shot-receives-11-million-for-treatment/ [4]  http://america.aljazeera.com/articles/2014/12/3/flu-vaccine-ineffective.html  [5]Skowronski DM, Leir S, et al. Influenza vaccine effectiveness by A (H3N2) phylogenetic subcluster and prior vaccination history: 2016–2017 and 2017–2018 epidemics in Canada. J Infectious Diseases, 2021; 225(8), 1387–1397. [6] Belongia EA, Skowronski DM, et al. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Review of Vaccines, 2023; 16(7), 743–759. [7]  Barbara Lo Fisher, The Emerging Risks of Live Virus and Virus Vectored Vaccines.  National Vaccine Information Center, 2014  [8]  http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM294307.pdf  [9] Barbara Lo Fisher, “CDC Admits Flu Shots Fail Half the Time.”  NVIC, October 19, 2016 [10] http://gaia-health.com/gaia-blog/2013-06-02/flu-vax-causes-5-5-times-more-respiratory-infections/  [11] Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season. Vaccine. 2019 Oct 10;38(2):350–354.   [12] Wolff GG. (2020). Influenza vaccination and respiratory virus interference among Department of Defense personnel. Vaccine, 2020 38(2), 350-354.  [13] Bodwes F, Janssens Y, et al. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology, 2021 13, 959379. DOI: 10.3389/fimmu.2022.959379  [14] Sinojoh M, Sugaya N, et al. Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in the 2022/23 season in Japan: The first season of co-circulation of influenza and COVID-19. Vaccine, 2022; 41(1), 100-107.  [15]  http://www.cbc.ca/news/health/flu-shot-linked-to-higher-incidence-of-flu-in-pandemic-year-1.1287363 [16]   Weinberg GA, Szilagyi PG. Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap. J Infect Dis 20210;201.1: 1607-610.  [17] ‘A Whole Industry Is Waiting For A Pandemic', Der Spiegel, http://www.spiegel.de/international/world/0,1518,637119-2,00.html, [18] Dolshi P. "Influenza: Marketing Vaccine by Marketing Disease." BMJ 2013;346: F3037.  [19] Simonsen L, Reichert T, et al. . Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population. Arch Intern Med Archives 2005;165(3): 265.  [20] Glezen WP, Simonsen L. Commentary: Benefits of Influenza Vaccine in US Elderly--new Studies Raise Questions. Internat J Epidemiology2006;35(2): 352-53. [21] 105th International Conference of the American Thoracic Sociey, May 15-20, 2009 (quoted in , Sherri Tenpenny.  “The Truth about Flu Shots”.  Idaho Observer, June 1, 2009)  [22] ibid  [23] Ibid.

In dieser Episode haben wir Annika Winn zu Gast. Annika ist nicht nur Physiotherapeutin, erfahrene Doula und Kursleiterin für prä- und postnatale Kurse mit Spezialisierung auf mentale Geburtsvorbereitung, sondern auch selbst Mutter. Sie teilt mit uns ihre Leidenschaft für die Doula-Arbeit und erklärt, wie Doulas werdende und neue Mamas sowie ihre Familien ganzheitlich begleiten und unterstützen können. Gemeinsam besprechen wir viele spannende Themen rund um die Doula-Begleitung. Wenn du also mehr über die Arbeit einer Doula erfahren und herausfinden möchtest, ob eine Doula auch für dich eine Bereicherung sein könnte, dann ist diese Episode genau richtig für dich.Schön, dass du dabei bist. Wir klären heute folgende Fragen:Was ist eine Doula?Welche Rolle übernimmt sie während Schwangerschaft, Geburt und im Wochenbett?Wozu brauche ich eine Doula?Wie unterscheidet sich ihre Unterstützung von der einer Hebamme?Welche wissenschaftlich belegten Vorteile bringt die Begleitung durch eine Doula?Wie wird eine Doula ausgebildet und welche Qualifikationen bringt sie mit?Was kostet eine Doula-Begleitung und werden die Kosten von der Krankenkasse übernommen?Worauf sollte ich bei der Wahl einer Doula achten?Wie kann eine Doula speziell bei Bauchgeburten, Risikoschwangerschaften oder Hausgeburten helfen?Was, wenn Familie oder Freunde der Doula-Unterstützung skeptisch gegenüberstehen?Kennst du schon unsere Apps? In der keleya Mama App findest du unsere Kurse zur Rückbildung, zum Stillen, zur Beikost-Einführung, für mehr Mindfulness, zum Babyschlaf, für das Wochenbett, zur Ersten Hilfe sowie Vieles mehr. Zudem haben wir für dich interessante Artikel, Videos und Audios speziell für das erste Baby-Lebensjahr zusammengestellt. Hier geht's zur Mama-App [https://keleya.de/mama-app/].Und für die aufregenden Monate vor der Geburt schau doch mal in unsere Schwangerschafts-App [https://keleya.de/schwangerschafts-app/]. Interessante Informationen, hilfreiche Praxistipps und wertvolle Anregungen warten auf dich.Vielen Dank an Annika Winn. Mehr Infos zu Annika findest du auf ihrer Webpage [https://becomemom.de/]. Quellen der Zahlen, Daten und Fakten aus der Episode:Bohren, M. A., Hofmeyr, G., Sakala, C., Fukuzawa, R. K., Cuthbert, A. (2017). Continuous support for women during childbirth. Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No.: CD003766. DOI: 10.1002/14651858.CD003766.pub6Hodnett, E. D., Gates, S., Hofmeyr, G. J., & Sakala, C. (2003). Continuous support for women during childbirth. The Cochrane database of systematic reviews, (3), CD003766. https://doi.org/10.1002/14651858.CD003766Klaus, M. H., & Kennell, J. H. (2021, 3. Auflage). Doula - Der neue Weg der Geburtsbegleitung. Berlin: Mosaik-VerlagWHO (2015). Safe childbirth Checklist. Abgerufen am 12.11.2024 unter https://iris.who.int/rest/bitstreams/886314/retrieveDanke für dein Interesse und Vertrauen. Von Herzen,Dein keleya Team… folge uns gern bei Instagram [@keleya.app] und Facebook [@getkeleya]. Hosted on Acast. See acast.com/privacy for more information.

What does the body of evidence say about smoking cessation? Does counselling make a difference and, if so, what kind? Is vaping effective as a way to quit smoking? And did you know there are drugs that have been shown to help give up the habit? Chris attempts to pronounce their names and is left with one question: is his veranda clean?   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Assistant researcher: Aigul Zaripova, MD Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information.   References: Reducing vs. quitting smoking 1) Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol. 2012 May 15;175(10):1006-12. doi: 10.1093/aje/kwr466. Epub 2012 Feb 3. PMID: 22306566. 2) Nina S. Godtfredsen, Claus Holst, Eva Prescott, Jørgen Vestbo, Merete Osler, Smoking Reduction, Smoking Cessation, and Mortality: A 16-year Follow-up of 19,732 Men and Women from the Copenhagen Centre for Prospective Population Studies, American Journal of Epidemiology, Volume 156, Issue 11, 1 December 2002, Pages 994–1001, https://doi.org/10.1093/aje/kwf150   Behavioural interventions for smoking cessation 3) Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD004492. doi: 10.1002/14651858.CD004492.pub4. PMID: 21069681. 4) Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Mar 24;3(3):CD008286. doi: 10.1002/14651858.CD008286.pub3. PMID: 27009521; PMCID: PMC10042551. 5) Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD009670. doi: 10.1002/14651858.CD009670.pub4. PMID: 31166007; PMCID: PMC6549450. 6) Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, Fanshawe TR, Lindson N, Freeman SC, Sutton AJ, Theodoulou A, Aveyard P. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2. PMID: 33411338; PMCID: PMC11354481. 7) Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016 Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22. PMID: 27116918.   Network meta-analysis of medications and e-cigarettes 8) Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, Hajizadeh A, Zhu S, Aveyard P, Freeman SC, Agrawal S, Hartmann-Boyce J. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses. Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No.: CD015226. DOI: 10.1002/14651858.CD015226.pub2. Accessed 04 November 2024.  

Over the last two years, there's been a rise in “immune-boosting” foods, supplements and trends. Today's guest, immunologist Dr. Jenna Macciochi, believes the immune system doesn't need boosting. Instead, it should be balanced. In this episode, Jenna - a Senior Lecturer in Immunology at the University of Sussex - reveals how your immune system is your body's housekeeper. Jenna highlights the case for the ‘good bugs' in our gut microbiome, the role of micronutrients and how our immune system isn't born, but made. We'll also tackle the age-old question: do we really need Vitamin C supplements?

Have you heard these myths about managing IBS with nutrition? Many believe that all dairy products should be eliminated, that all legumes cause discomfort, and that switching to a gluten-free diet is the key. But what if I told you that these myths could be harming your gut health? Stay tuned as I reveal the truth behind these common misconceptions and share a practical approach to managing IBS with nutrition. In this episode, you will be able to: Discover effective ways to manage IBS through dietary adjustments. Unlock the power of specific foods that can bring relief to IBS symptoms. Learn how to navigate lactose intolerance while managing IBS for a happier gut. Uncover the surprising benefits of incorporating fatty fish into your diet for improved gut health. Explore a variety of soluble fiber sources that can aid in managing IBS effectively. Episode links: Free Hormone + Gut Health Toolkit 1-on-1 nutrition coaching References: Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2020;2020(3).   Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. The American journal of clinical nutrition. 1996;64(2):232-6. Suarez FL, Savaiano D, Arbisi P, Levitt MD. Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance. The American journal of clinical nutrition. 1997;65(5):1502-6.

 Zinc and the Common Cold: What You Need to KnowWhat does zinc do for the body? Zinc is an essential trace element vital for immune function, wound healing, and DNA synthesis. It supports over 300 enzymes and the proper function of immune cells like T-cells and macrophages. Zinc also aids in the production of antibodies that fight infections.A recent review in the Cochrane Database of Systematic Reviews found that zinc supplements might not prevent colds, but taking zinc at the onset of symptoms can reduce the duration by about two days. This represents a 10-20% decrease in illness length, which is clinically significant.Takeaways:1. Zinc element in immunity: vital for immune cell function and enzyme activity, making it crucial in fighting infections.2. Supplementation: Zinc gluconate and zinc acetate lozenges may effectively reduce cold duration if taken within 24 hours of cold symptoms.3. Zinc supplementation reduces sick days of the common cold, but does not affect the odds of catching a cold or symptom severity.4. Zinc deficiency: Can lead to significant health issues, emphasizing the need for adequate intake.Safety note: Zinc supplements are generally well-tolerated, but high doses can cause nausea and gastrointestinal distress. Do not exceed the Tolerable Upper Intake Level of 40 mg/day regularly for adults without medical supervision.What zinc should I take? Zinc gluconate and zinc acetate lozenges can be effective for boosting the immune system during colds. They can reduce the duration of symptoms if taken at the onset of illness. Consult your healthcare provider before starting any supplement regimen.Zinc deficiency symptoms:Weakened immune responseHair lossDiarrheaDelayed wound healingLoss of appetiteImpaired growth and development in childrenBenefits of zinc:Zinc Benefits For Men: Supports testosterone production, muscle growth, and overall immunity.Zinc Benefits for Women: Crucial for reproductive health, skin health, and immune function.Zinc-rich foods:Red meatSeafood (especially oysters)PoultryBeansNutsWhole grainsDairy productsStay informed, stay healthy.References:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543785/https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014914.pub2/full Support the Show.

Remember when we learned interruptions in compressions take a long time to recover blood pressure from? And how, to avoid these, we should do continuous compressions to avoid them. And ventilations aren't all that important. Right? Right? Well, about that. Maybe the stories of the importance of continuous compressions were greatly exaggerated. Join Dr. Jarvis as he discusses the literature that led us to this point and some evidence that has led him to reconsider how his system approaches cardiac arrest. He'll eventually get around to discussion a recent paper by Dr. Rose Yin that analyzes arterial pressures during cardiac arrest that was a catalyst for him to make changes in his arrest protocols. Citations:1. Yin RT, Berve PO, Skaalhegg T, et al. Recovery of arterial blood pressure after chest compression pauses in patients with out-of-hospital cardiac arrest. Resuscitation. 2024;201:110311. doi:10.1016/j.resuscitation.2024.110311 2. Azcarate I, Urigüen JA, Leturiondo M, et al. The Role of Chest Compressions on Ventilation during Advanced Cardiopulmonary Resuscitation. JCM. 2023;12(21):6918. doi:10.3390/jcm122169183. Berg RA, Sanders AB, Kern KB, et al. Adverse Hemodynamic Effects of Interrupting Chest Compressions for Rescue Breathing During Cardiopulmonary Resuscitation for Ventricular Fibrillation Cardiac Arrest. Circulation. 2001;104(20):2465-2470. doi:10.1161/hc4501.0989264.Kern KB, Hilwig RonaldW, Berg RA, Ewy GA. Efficacy of chest compression-only BLS CPR in the presence of an occluded airway. Resuscitation. 1998;39(3):179-188. doi:10.1016/S0300-9572(98)00141-55. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally Interrupted Cardiac Resuscitation by Emergency Medical Services for Out-of-Hospital Cardiac Arrest. JAMA. 2008;299(10):1158-1165.6. Idris AH, Aramendi Ecenarro E, Leroux B, et al. Bag-Valve-Mask Ventilation and Survival From Out-of-Hospital Cardiac Arrest: A Multicenter Study. Circulation. 2023;148(23):1847-1856. doi:10.1161/CIRCULATIONAHA.123.0655617. Nichol G, Leroux B, Wang H, et al. Trial of Continuous or Interrupted Chest Compressions during CPR. N Engl J Med. 2015;373(23):2203-2214. doi:10.1056/NEJMoa1509139 8. Schmicker RH, Nichol G, Kudenchuk P, et al. CPR compression strategy 30:2 is difficult to adhere to, but has better survival than continuous chest compressions when done correctly. Resuscitation. 2021;165:31-37. doi:10.1016/j.resuscitation.2021.05.027 9. Zhan L, Yang LJ, Huang Y, He Q, Liu GJ. Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation of non-asphyxial out-of-hospital cardiac arrest. Cochrane Anaesthesia C and ECG, ed. Cochrane Database of Systematic Reviews. Published online 2017. doi:10.1002/14651858.cd010134.pub2 10. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation. 2004;109(16):1960-1965. doi:10.1161/01.CIR.0000126594.79136.61

In this episode:Why it's so difficult to find an effective solution to chronic low back painBreaking down common myths about chronic low back pain How beliefs about back pain can negatively impact on recoveryThe problem with existing treatment approaches The Pain Puzzle is an educational series designed to bring you the latest science underpinning effective management of chronic low back pain. This series will help you understand chronic low back pain and how you can use mind-based therapies to better manage your pain and get back to the life you love.This episode of the Pain Puzzle is brought to you by Relio.Relio is a science-backed digital program that combines cutting-edge pain science education with the effective power of clinical hypnosis to get to the root cause of your pain.Website: reliohealth.comApp storeGoogle Play storeReferences:Magnetic resonance imaging of the lumbar spine in people without back pain.Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. Clinical Pain Management: A Practical Guide. What happens to the lower lumbar spine after marathon running: a 3.0 T MRI study of 21 first-time marathoners.Relationship of significance of wound to pain experienced.Non-specific low back pain.Chronic Pain. Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis. Spinal cord stimulation for low back pain. Cochrane Database of Systematic Reviews 2023.Clinical Care Guidelines for Chronic Low Back Pain.Disclaimer:The content in this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare practitioner. Never disregard professional medical advice or delay seeking it because of topics discussed in this podcast.

COME DIRE ADDIO ALLE SIGARETTE E ALLE SIGARETTE ELETTRONICHE?scopri di più:https://www.claudiosaracino.com/prodotto/no-fumo-metodo-dcs/#smetteredifumare#sigarette #sigaretteelettronicheCome Smettere di Fumare Sigarette con l'Ipnosi Vera e ProfessionaleFumare sigarette è una delle abitudini più dannose per la salute umana, ma è anche una delle più difficili da abbandonare. Tuttavia, negli ultimi anni, l'ipnosi si è rivelata una tecnica promettente per aiutare le persone a smettere di fumare. Questo tema esplorerà come l'ipnosi professionale può essere utilizzata per combattere la dipendenza da nicotina, citando ricerche scientifiche accreditate e testimonianze di personaggi famosi che hanno avuto successo con questa metodologia.Ricerche Scientifiche sull'Efficacia dell'Ipnosi per Smettere di FumareAmerican Journal of Clinical Hypnosis (2014): Uno studio condotto da Lynn et al. ha dimostrato che l'ipnosi ha un tasso di successo del 50% superiore rispetto alle tecniche di counseling tradizionali nel trattamento della dipendenza da tabacco.Journal of Consulting and Clinical Psychology (2000): Elkins e Rajab hanno riscontrato che l'ipnosi è stata efficace nel 60% dei casi di soggetti trattati per smettere di fumare, rispetto al 25% dei trattamenti standard.International Journal of Clinical and Experimental Hypnosis (2008): Uno studio di Green e Lynn ha evidenziato come l'ipnosi possa ridurre significativamente il desiderio di fumare nei partecipanti, con effetti positivi duraturi.Cochrane Database of Systematic Reviews (2019): Una revisione di vari studi ha concluso che l'ipnosi può essere utile per smettere di fumare, sebbene siano necessari ulteriori studi per consolidare queste prove.Addictive Behaviors (1992): Johnson e Karkut hanno trovato che l'ipnosi ha un tasso di successo del 90% nel gruppo di fumatori cronici che hanno partecipato allo studio.American Journal of Health Promotion (1998): Uno studio di Hasen ha riportato un tasso di astinenza dal fumo del 81% nei partecipanti trattati con ipnosi dopo 12 mesi.Annals of the New York Academy of Sciences (2002): I ricercatori Miller e Bowers hanno documentato che l'ipnosi combinata con terapie comportamentali aumenta significativamente le possibilità di smettere di fumare.European Journal of Public Health (2013): Uno studio condotto da Schmidt et al. ha dimostrato che l'ipnosi ha un tasso di successo del 48% tra i fumatori che cercavano di smettere.British Medical Journal (1999): Uno studio di Carmody e Vieten ha concluso che i partecipanti sottoposti a ipnosi hanno mostrato una riduzione del 50% nel consumo di sigarette rispetto al gruppo di controllo.Psychological Reports (1995): Uno studio di Perry et al. ha dimostrato che il 70% dei fumatori sottoposti a ipnosi ha smesso di fumare dopo sei mesi di trattamento.Testimonianze di Personaggi FamosiEllen DeGeneres: La famosa conduttrice televisiva ha dichiarato pubblicamente di essere riuscita a smettere di fumare grazie all'ipnosi. DeGeneres ha descritto l'esperienza come un punto di svolta nella sua lotta contro la dipendenza da nicotina.Ashton Kutcher: L'attore e imprenditore Ashton Kutcher ha rivelato di aver utilizzato l'ipnosi per smettere di fumare. Kutcher ha parlato positivamente dell'efficacia dell'ipnosi, affermando che ha trasformato la sua vita.Matt Damon: Il pluripremiato attore Matt Damon ha attribuito il suo successo nel smettere di fumare all'ipnosi. Damon ha raccontato come una sola sessione di ipnosi abbia eliminato il suo desiderio di fumare, rendendo facile per lui abbandonare la sigaretta.ConclusioniL'ipnosi professionale si è dimostrata una tecnica efficace e promettente per aiutare le persone a smettere di fumare. Numerosi studi scientifici hanno confermato la validità di questo approccio, dimostrando che può essere significativamente più efficace rispetto alle tecniche tradizionali. Inoltre, testimonianze di personaggi famosi come Ellen DeGeneres, Ashton Kutcher e Matt Damon forniscono ulteriori prove del successo dell'ipnosi nel combattere la dipendenza da nicotina. Chiunque stia lottando per smettere di fumare potrebbe considerare l'ipnosi come una valida opzione terapeutica.

If you're feeling exhausted from sifting through conflicting and often unhelpful diet advice for managing PCOS and IBS, constantly craving, experiencing digestive discomfort, and struggling to find relief from your symptoms, then you are not alone! In this episode of Joyful Eating with PCOS, Trista Chan, a registered dietitian and founder of the Good Life Dietitian, dives into the challenges faced by individuals dealing with PCOS and IBS. In this episode, we discuss: Discover how to manage PCOS and IBS through simple dietary changes. Uncover the power of supplements for improving PCOS and gut health. Explore the benefits of exercise for managing PCOS and IBS symptoms. Learn the art of mindful eating to balance your hormones and well-being. Understand the importance of quality sleep in effective PCOS management. Resources: PCOS Recovery Program https://www.thegoodlifedietitian.com/pcos-recovery-program Follow Trista and the team at https://www.instagram.com/thegoodlifedietitian/ References: Monash University. (2023). International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. https://doi.org/10.26180/24003834.v1 Malone, J. C., & Thavamani, A. (2023). Physiology, gastrocolic reflex. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549888/ Manta, A., Paschou, S. A., Isari, G., Mavroeidi, I., Kalantaridou, S., & Peppa, M. (2023). Glycemic index and glycemic load estimates in the dietary approach of polycystic ovary syndrome. Nutrients, 15(15), 3483. https://doi.org/10.3390/nu15153483 Nunan, D., Cai, T., Gardener, A. D., Ordóñez-Mena, J. M., Roberts, N. W., Thomas, E. T., & Mahtani, K. R. (2022). Physical activity for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, 2022(6), CD011497. https://doi.org/10.1002/14651858.CD011497.pub2 Fernandez, R. C., Moore, V. M., Van Ryswyk, E. M., Varcoe, T. J., Rodgers, R. J., March, W. A., Moran, L. J., Avery, J. C., McEvoy, R. D., & Davies, M. J. (2018). Sleep disturbances in women with polycystic ovary syndrome: Prevalence, pathophysiology, impact and management strategies. Nature and Science of Sleep, 10, 45-64. https://doi.org/10.2147/NSS.S127475799701.

In this episode, we explore Carl Rogers' 'Curious Paradox'—the concept that true change comes from self-acceptance. We'll talk about the historical context of Rogers' humanistic psychology and his focus on unconditional positive regard and person-centered therapy. The big takeaway is the profound impact self-acceptance and self-compassion have on behavior change and healing.    Watch this episode on YouTube.   Key moments: 00:00 Welcome to Joy Lab 00:39 Introducing the Curious Paradox 01:35 About Carl Rogers 05:00 The Power of Self-Acceptance 09:39 Personal Stories of Self-Acceptance 13:29 Embracing Authenticity 20:40 Closing Thoughts and Wisdom    Joy Lab and Natural Mental Health are community-supported. When you buy through the links below, we may earn a commission. That support helps keeps the Joy Lab podcast free for all!   Sources and Notes: Joy Lab Program: Take the next leap in your wellbeing journey with step-by-step practices to help you build and maintain the elements of joy in your life. Your Joy Lab membership also includes our NMH Community! NMH Community: Access lots of extra resilience-boosting resources AND join a group of inspiring folks who play an integral role in keeping this podcast going. Many of our serotonin-supporting resources and additional self-care strategies can be found in your Resilience Mini Course. If you don't have your Course yet, simply take the Free Resilience Quiz and then sign up for your free Mini Course to identify your mental health strengths and obstacles and take meaningful actions to support your resilience. Gabrielle Calvocoressi's website. Where to shop: Our partner store at Fullscript: This is where you can find high-quality supplements and wellness products. Except for our CBD Gummies, any product links mentioned in the show notes below will require an account. Sign up for your free Fullscript account here: https://us.fullscript.com/welcome/nmh/store-start Resilient Remedies: This is where you can find our line of trusted, high-quality CBD gummies: https://www.resilientremedies.com/ Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive behaviors, 97, 111–121. Van Leeuwen E, et al. (2021). Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database of Systematic Reviews 2021. Subscribe to our Newsletter: Join us over at NaturalMentalHealth.com for exclusive emails, updates, and additional strategies. Check out our favorite resilience-boosting reads: https://bookshop.org/shop/NMHreads    Please remember that this content is for informational and educational purposes only. It is not intended to provide medical advice and is not a replacement for advice and treatment from a medical professional. Please consult your doctor or other qualified health professional before beginning any diet change, supplement, or lifestyle program. Please see our terms for more information. If you or someone you know is struggling or in crisis, help is available. Call the NAMI HelpLine: 1-800-950-6264 available Monday through Friday, 10 a.m. – 10 p.m., ET. OR text "HelpLine" to 62640 or email NAMI at helpline@nami.org. Visit NAMI for more. You can also call or text SAMHSA at 988 or chat 988lifeline.org.  

In this episode, we talk about the experience of coming off antidepressants. It's important to note that there is a serious lack of attention and research on antidepressant withdrawal compared to starting these medications. We'll talk about  the challenges of withdrawal symptoms, the importance of patient voices in healthcare research, and best practices for tapering off medications. We'll also touch on some natural ways to support the serotonin system during withdrawal, such as using supplements like 5-HTP. We hope this episode helps spread information about the realities of antidepressant withdrawal and that folks can have a more well-informed approach in collaboration with healthcare providers to navigate this process with less negative symptoms. Joy Lab and Natural Mental Health are community-supported. When you buy through the links below, we may earn a commission. That support helps keep the Joy Lab podcast free for all!   Sources and Notes: Joy Lab Program: Take the next leap in your wellbeing journey with step-by-step practices to help you build and maintain the elements of joy in your life. Your Joy Lab membership also includes our NMH Community! NMH Community: Access lots of extra resilience-boosting resources AND join a group of inspiring folks who play an integral role in keeping this podcast going. Many of our serotonin-supporting resources and additional self-care strategies can be found in your Resilience Mini Course. If you don't have your Course yet, simply take the Free Resilience Quiz and then sign up for your free Mini Course to identify your mental health strengths and obstacles and take meaningful actions to support your resilience. Gabrielle Calvocoressi's website. Where to shop: Our partner store at Fullscript: This is where you can find high-quality supplements and wellness products. Except for our CBD Gummies, any product links mentioned in the show notes below will require an account. Sign up for free. Resilient Remedies: This is where you can find our line of trusted, high-quality CBD gummies. Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive behaviors, 97, 111–121. Van Leeuwen E, et al. (2021). Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database of Systematic Reviews 2021. Subscribe to our Newsletter: Join us over at NaturalMentalHealth.com for exclusive emails, updates, and additional strategies. Check out our favorite resilience-boosting reads. Full transcript here. Please remember that this content is for informational and educational purposes only. It is not intended to provide medical advice and is not a replacement for advice and treatment from a medical professional. Please consult your doctor or other qualified health professional before beginning any diet change, supplement, or lifestyle program. Please see our terms for more information. If you or someone you know is struggling or in crisis, help is available. Call the NAMI HelpLine: 1-800-950-6264 available Monday through Friday, 10 a.m. – 10 p.m., ET. OR text "HelpLine" to 62640 or email NAMI at helpline@nami.org. Visit NAMI for more. You can also call or text SAMHSA at 988 or chat 988lifeline.org.  

Gosh was I lucky to speak with Professor Erik Van Zwet from Leiden University in the Netherlands. He is the first author on a recent NEJM Evidence paper looking at more than 23,000 trials in the Cochrane Database. (I linked to an URL that should get by the paywall.) There are technical aspects of this paper. We hit on some (not a lot) of them. The gist of it though is really important when we look at evidence. Erik did an excellent job of explaining P-values, trial power, and, at the end, we discuss how this work might inform the ability of trials to replicate. This discussion also pairs well with one I had with computer scientist Ben Recht. I hope you enjoy the conversation. Please do consider subscribing or supporting our work as Sensible Medicine remains an ad-free user-supported place to learn about medical evidence. JMM Sensible Medicine is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

In this episode we hear from our very own Elysia, as she and her husband Andrew give us a snapshot of their first three birth experiences — the first two in integrated birth centres in the UK, the third in a Melbourne public hospital, before delving into what led them to choose homebirth for their most recent birth of baby number 4, at home via a publicly funded homebirth program. We discuss the cultural and social influences on your choices around how and where to birth, as well as the journey towards choosing homebirth. We touch on Elysia's experience of a third degree tear in her first birth (and the improved perineal outcomes with each subsequent birth), and when it came to homebirth — the common partner questions, the role of a student midwife, and their reflections on just how different that model of care, and experience of being in your own home was, for both Elysia and Andrew. Links:- The Great Birth Rebellion on Group B Strep (GBS) and Pushing Out Your Baby- The Midwives Cauldron episode on Gestational Diabetes - Rachel Reed on Big Babies - Cochrane Review into midwifery-led continuity of care: Sandall, J., Soltani, H., Gates, S., Shennan, A., & Devane, D. (2015). Midwife-led continuity models versus other models of care for childbearing women. Cochrane Database of Systematic Reviews, 9, CD004667–CD004667. https://doi.org/10.1002/14651858.CD004667.pub4Birth Choices, through this website and our podcast, aims to share stories and collate information to assist you in navigating your pregnancy and birth and in discussing these choices with your chosen pregnancy care provider. The information and resources provided are informational and educational in nature and does not constitute medical or midwifery advice and shall not be construed as constituting or replacing medical or midwifery advice. While we have worked hard to ensure that the information we provide is accurate and based on reliable and up to date evidence, we do not warrant or guarantee the accuracy of this information. Our website and podcast are intended to complement, and never to substitute, your midwifery or medical clinical care. 

This is Part 1 of our care provider choices mini-series. In this episode we walk you through the care provider options available to you for pregnancy, birth and postpartum care. We discuss care under the public system - from fragmented general care, to caseload/MGP continuity models, publicly funded Homebirth, and shared care with a GP or private midwife, as well as care from private midwives and private obstetricians. Choosing your car provider matters, and it shouldn't just be a case of whether you do or don't have private health insurance. To read more about your care provider choices — head to www.birthchoices.com.au/careproviderLinks:Cochrane Review into midwifery-led continuity of care: Sandall, J., Soltani, H., Gates, S., Shennan, A., & Devane, D. (2015). Midwife-led continuity models versus other models of care for childbearing women. Cochrane Database of Systematic Reviews, 9, CD004667–CD004667. https://doi.org/10.1002/14651858.CD004667.pub4Study comparing caseload midwifery with standard or private obstetric care for first time mothers — ​​Tracy, S. K., Welsh, A., Hall, B., Hartz, D., Lainchbury, A., Bisits, A., White, J., & Tracy, M. B. (2014). Caseload midwifery compared to standard or private obstetric care for first time mothers in a public teaching hospital in Australia: a cross sectional study of cost and birth outcomes. BMC Pregnancy and Childbirth, 14(1), 46–46. https://doi.org/10.1186/1471-2393-14-46“Factors promoting or inhibiting normal birth”: Prosser, S. J., Barnett, A. G., & Miller, Y. D. (2018). Factors promoting or inhibiting normal birth. BMC Pregnancy and Childbirth, 18(1), 241–241. https://doi.org/10.1186/s12884-018-1871-5“What women want if they were to have another baby: the Australian Birth Experience Study (BESt) cross-sectional national survey”: Keedle, H., Lockwood, R., Keedle, W., Susic, D., & Dahlen, H. G. (2023). What women want if they were to have another baby: the Australian Birth Experience Study (BESt) cross-sectional national survey. BMJ Open, 13(9), e071582–e071582. https://doi.org/10.1136/bmjopen-2023-071582A content analysis of women's experiences of different models of maternity care: Pelak, H., Dahlen, H. G., & Keedle, H. (2023). A content analysis of women's experiences of different models of maternity care: the Birth Experience Study (BESt). BMC Pregnancy and Childbirth, 23(1), 864–864. https://doi.org/10.1186/s12884-023-06130-2Disclaimer: This podcast aims to share stories and education to assist you in navigating your pregnancy and birth and in discussing these choices with your chosen pregnancy care provider. The information and resources provided are educational in nature and do not constitute or replace medical or midwifery advice. While we have worked hard to ensure that the information we provide is accurate and based on reliable and up to date evidence, we do not warrant or guarantee the accuracy of this information. Our website and podcast are intended to complement, and never to substitute, your midwifery or medical clinical care. 

Dr. Zach Cost and Dr. Tem Bendapudi join the show to discuss the literature pertaining to tranexamic acid and thromboembolic risk. Dr. Zach Cost is an anesthesia resident at the Massachusetts General Hospital. Dr. Pavan (“Tem”) Bendapudi holds a joint faculty appointment in the Division of Hematology and Blood Transfusion Service and is assistant professor of medicine at Harvard Medical School. This podcast was recorded as part of the Depth of Anesthesia podcast elective. Thanks for listening! If you enjoy our content, leave a 5-star review on Apple Podcasts and share our content with your colleagues. — Follow us on Instagram @DepthofAnesthesia and on Twitter (X) @DepthAnesthesia for podcast and literature updates. Email us at depthofanesthesia@gmail.com with episode ideas or if you'd like to join our team. Music by Stephen Campbell, MD. — References CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. PMID: 20554319. Henry DA, Carless PA, Moxey AJ, et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2011;(1). doi:10.1002/14651858.CD001886.pub3 Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. doi:10.1136/bmj.e3054 Myles PS, Smith JA, Forbes A, et al. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. New England Journal of Medicine. 2017;376(2):136-148. doi:10.1056/NEJMoa1606424 Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. New England Journal of Medicine. 2022;386(21):1986-1997. doi:10.1056/NEJMoa2201171 POISE 3 PeriOperative ISchemic Evaluation-3 (POISE-3) study Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum hemorrhage (WOMAN): an international, randomized, double-blind, placebo-controlled trial. The Lancet. 2017;389(10084):2105-2116. doi:10.1016/S0140-6736(17)30638-4 Roberts I, Shakur-Still H, Afolabi A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. The Lancet. 2020;395(10241):1927-1936. doi:10.1016/S0140-6736(20)30848-5 Taeuber I, Weibel S, Herrmann E, et al. Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Surgery. 2021;156(6):e210884. doi:10.1001/jamasurg.2021.0884

Having a larger waistline is linked to a whole host of risks, including higher propensity for heart disease and diabetes. And while it isn't possible to directly target belly fat through exercise and diet, there are some steps you can take to facilitate overall fat loss, resulting in a reduction of dangerous visceral fat. Today's guest, Thomas DeLauer, is an expert in the realm of diet and nutrition. His popular YouTube channel has amassed millions of subscribers with the mission of helping folks implement realistic and sustainable habits to optimize their health. On this episode of The Model Health Show, he's diving into the science behind losing belly fat. You're going to learn the critical mechanisms behind belly fat, including the role of hormones, calories, macronutrients, and more. You'll hear about the best types of exercise for reducing fat, how to simplify your diet for better body composition, and a whole lot more. Thomas has a wealth of knowledge in this space, and I hope you enjoy this interview. In this episode you'll discover: What central adiposity is. The difference between visceral fat and belly fat. What the main culprits of visceral adiposity are. How cortisol works in relation to belly fat. Why so many people are skinny fat. How trans fats are created, and how the body breaks them down. The connection between leaky gut and inflammation. What you need to know about trans fats in our food supply. Why both excess sugar and excess fat can cause elevated blood sugar levels. How the liver stores and utilizes glycogen. Why processed foods create the perfect storm for accumulating belly fat. The mechanisms behind how the body burns fat. Which types of exercise are best for burning belly fat. The truth about spot reduction. What LISS is, and how to utilize it. Thomas' story of transforming his health. The first thing you should do daily to start your day off right. A meal prep tip to help you simplify your life. How to create an environment that facilitates healthy choices. Items mentioned in this episode include: DrinkLMNT.com/model -- Get a FREE sample pack with any order! HVMN.com/model -- Save 30% on your first subscription order of Ketone-IQ! EatSmarterCookbook.com Connect with Thomas DeLauer Website / Instagram / YouTube Join TMHS Facebook community - Model Nation  Be sure you are subscribed to this podcast to automatically receive your episodes:  Apple Podcasts Stitcher Spotify Soundcloud   Thanks To Our Sponsors   This episode is brought to you by LMNT. Now, one of the most essential things that enables our cells to literally talk to each other, that enables signal transduction are electrolytes. Electrolytes are minerals that carry an electric charge. Now, there's a certain electrolyte that has gotten drag through the media, through popular culture and really framed as a villain, and that electrolyte is sodium. Now, according to the FDA, over 70% of the sodium in the average American's diet is coming from ultra-processed fake foods. It's coming from ultra-processed foods, from things like Pop-Tarts and potato chips, and the list goes on and on, fast foods. This is where we're getting the bulk of our sodium intake, very low quality sodium and really a one-trick pony because there isn't just one type of electrolyte or one type of sodium. Sodium is one form of a salt. There's also potassium salts, there's also magnesium salts. There's many forms of magnesium, many forms of sodium. That highly refined sodium found in ultra-processed foods, that can be problematic, absolutely. But what happens when we start to shift away from having a diet largely made up of these ultra-processed foods and we're eating more real foods? Are we certain that we're getting the sodium that our cells really need to have a high level of communication and also to protect our metabolic health? Because a meta-analysis published in the Cochrane Database of Systematic Reviews uncovered that study participants placed on a low sodium diet did have slightly lower blood pressure in the short-term because that's what we often think about when reducing the sodium, is because of hypertension. So they found that lowering sodium intake did slightly lower blood pressure in the short-term, but they found that restricted sodium also led in the more medium to longer-term, eventually led to elevated triglycerides or blood fats, elevated stress hormones, and accordingly elevated blood pressure. So short-term, reducing sodium, reduces blood pressure, but if you do that for too long, blood pressure is going to be elevated. So there's a balance here. We need sodium. It is a critical nutrient to human health, but we don't want it coming in in that one-trick pony version from ultra-processed foods predominantly. And also a study that was published in the Journal Metabolism that was done by researchers at Harvard Medical School found that low salt intake directly increases insulin resistance in healthy test subjects. So with that being said, make sure that we're eating foods that are naturally rich in sodium, but also what I saw at my special guest recording studio, what we have here at our studio is the electrolytes from LMNT. Go to drinklmnt.com/model and you're going to get the highest quality electrolyte supplement in the world. And they're also, by the way, with every electrolyte purchase, they're going to send you a free bonus pack, a free gift as well. Now, a fascinating study published in the journal Neuron found that magnesium, which is one of the other electrolytes in LMNT, incredible ratios, magnesium is able to restore critical brain plasticity and improve our cognitive function, right? So our brain is critically dependent on sodium, magnesium, and potassium is the other key electrolyte in this equation. And LMNT has hundreds of thousands of data points on the optimal ratio of these electrolytes. And by the way, professional sports teams and all professional sports are utilizing LMNT now. Just because contractually they got to have Gatorade on the outside of that container on the sidelines. I'm telling you right now, I've got the inside information here. Many professional teams are now utilizing LMNT, and I know this because these high level athletes and teams are now partnering with LMNT. So again, it's something really special. It's getting away from all the highly refined sugar that's unnecessary to have in our electrolyte supplements and just delivering the high quality electrolytes that our bodies need to perform. Go to drinklmnt.com/model for a special gift of electrolytes with every purchase.   This episode is brought to you by HVMN. One of the major reasons that people give for not being able to cook home-cooked meals on a consistent basis, is not having the energy to do it. Energy can be one of our greatest assets, and it can also be one of our greatest deficiencies. Obviously, our lifestyle factors play a huge role in the availability that we have to access energy, but there are a few recent discoveries that are adding to energy equation, like a few things ever have. Numerous studies, including a study published by the Federation of American societies for Experimental Biology or the FASEB journal, found that exogenous ketones can be up to 28% more efficient in generating energy than glucose alone. If this is about cognitive function, if this is about energy, you've got to utilize these ketones, but not just any run-of-the-mill ketone esters that had its time in the sun, but something far better has been brought to the world by HVMN. Go to hvmn.com/model, and you're going to get 30% off your first subscription order of ketone-IQ. Ketone-IQ is now clinically proven to improve our cognitive performance and also bolster our energy for sports performance. In fact, studies have found up to 15% increased mean power output after recovery by utilizing ketones. And the bio-availability of ketone IQ is in a league of its own. Check out ketone-IQ today. Go to hvmn.com/model for 30% off your first subscription order.

This week you get TWO entrees with a little trip to the dessert cart! Julie and Jeremy picked some juicy stories from health headlines, strained out the inedible parts, and left you the sweet nectar. Let's gobble up the "brain nutrition" that helps YOU feel more empowered to appraise health stories in the news. This week's HEALTH HEADLINES include:Why do women pay more out-of-pocket for healthcare in the US? Julie breaks down a Deloitte analysis, and teaches Jeremy about the PINK TAX, and how it's EVERYWHERE (including in our insurance healthcare costs).Do LED light masks actually work? Do they result in younger-looking skin, less wrinkles, and fewer acne breakouts? Or are they just a scary cross-between-Jason-and-Ironman looking facial accessory??Our "Dessert Cart" contains quick bites about blood tests for long COVID, expiration dates for COVID tests, and cannabis-related car crashes and ER visits. Resources for today's topics include:Deloitte's analysis- "Hiding in plain sight: The health care gender toll." The CDC's Summary Health Statistics: National Health Interview Survey 2018.A 2019 Harvard Health Article- "Mars vs Venus: The gender gap in health."The Hysteria Podcast on Crooked Media (Sept 28 Episode features the Deloitte Analysis)(lol not scientific, but funny) A HuffPo Listicle about THE PINK TAX.American Society of Plastic Surgeons website on "What is LED light therapy and what are the benefits?"Harvard Health Article- "LED lights: Are they a cure for your skin woes?"Annals of Family Medicine article- "Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis".Cochrane Database of Systematic Reviews- "Light therapies for acne."An article from Photomedicine and Laser Surgery on red-light therapy for facial skin. A Healthline article- "LED Light Therapy for Skin: What to Know."Healio article- "Traffic injury ED visits involving cannabis grow over recent years."For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow

In this episode we talk with Emily Chandler and Taylor Washburn, EBB Childbirth Class graduates about their experiences in the childbirth class; their informed and empowered hospital birth; and how they navigated an extended hospital stay for newborn jaundice.   Emily, is a marine scientist, and Taylor, is a teacher and rowing coach in the Boston area. Together, they love hiking, biking, rowing, and taking advantage of the great outdoors. And they're also very busy taking care of their baby. While pregnant, Emily dove headfirst into learning about pregnancy, birth, and the state of maternity care in the United States. Emily and Taylor took the Evidence Based Birth Childbirth Class with EBB instructor Chanté Perryman.   Emily and Taylor share their experiences in the EBB Childbirth Class and how that informed many of the decisions they made regarding their birth plan, including Taylor being both inspired and empowered to “catch” their baby. They also share how they used the advocacy skills learned in class to better communicate with their providers and each other. After experiencing the birth they desired, complications arose when Emily experienced difficulty breastfeeding and inadequate lactation support. Difficulty was further exasperated when their newborn was diagnosed with jaundice leading to an extended hospital stay. Content Warnings: extended hospital stay due to newborn jaundice, “yellow baby,” difficulty breastfeeding, syringe feeding, lack of lactation support poor latch, heel pricks and bilirubin testing, treatment for elevated bilirubin, poor outcomes for Black and Brown infants with jaundice Resources: Access the CDC article on Jaundcie here Access the Evidence Based Birth® Signautre Articles on:  The Evidence on Premature Rupture of Membranes here  The Evidence on Group B Strep here  The Evidence on Pitocin® in the Third Stage here Listen to EBB 145- Fatherhood and Advocacy in Birth with JacMichael Perryman here Listen to EBB 244 - Evidence on AROM, AVD and Internal Monitoring here  Learn more about Chanté Perryman's EBB Childbirth Class and services here or on her Instagram account @babydreamsmc Learn more about The Nest Collaborative for lacation support here References:  Here are the scientific references on jaundice for the blog article: ·      Dunn, P. M. (2003). Dr Erasmus Darwin (1731–1802) of Lichfield and placental respiration. Arch Dis Child Fetal Neonatal Ed;88:F346– 8. ·      Katheria, A. C., Lakshminrusimha, S., Rabe, H., et al. (2017). Placental transfusion: a review. Journal of Perinatology; 37:105-111. ·      McDonald, S. J., Middleton, P., Dowswell, T., et al. (2013). Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database of Systematic Reviews, Issue 7. Art. No.: CD004074 ·      Ashish, K. C., Rana, N., Malqvist, M., et al. (2017). Effects of Delayed Umbilical Cord Clamping vs. Early Clamping on Anemia in Infants at 8 and 12 months: A Randomized Clinical Trial. JAMA Pediatr;171(3):264-270. ·      Mercer, J. S., Erickson-Owens, D. A., Deoni, S. C. L., et al. (2018). Effects of Delayed Cord Clamping on Four-Month Ferritin Levels, Brain Myselin Content, and Neurodevelopment: A Randomized Controlled Trial. ·      Andersson, O., Lindquist, B., Lindgren, M., et al. (2015). Effect of delayed cord clamping on neurodevelopment at 4 years of age: a randomized clinical trial. JAMA Pediatr;169:631–8. ·      CDC article on Jaundice: https://www.cdc.gov/ncbddd/jaundice/facts.html   Go to our YouTube channel to see video versions of the episode listed above!! For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on:  TikTok Instagram Pinterest Ready to get involved?  Check out our Professional membership (including scholarship options) here  Find an EBB Instructor here  Click here to learn more about the Evidence Based Birth® Childbirth Class.  

Cochrane Library's recently published article questioning the clinical benefit of spinal cord stimulation for low back pain has stirred controversy throughout the pain medicine community. In response to these findings, we sat down with neuromodulation specialists & Pain Medicine journal editorial board members,  Zachary McCormick, MD, and Nathaniel M. Schuster, MD, to offer our in-depth reaction and analysis of the March 2023 report. In this episode of the Pain Matters Podcast, host Shravani Durbhakula, MD, MPH, MBA, and co-host @Mustafa Broachwala, DO, are joined by Zachary McCormick, MD, Chief of Spine and Musculoskeletal Medicine at the University of Utah & Nathaniel M. Schuster, MD, Associate Clinical Director of the Center for Pain Medicine at UC San Diego. We are live in-person at AAPM's 39th Annual Meeting in Fort Lauderdale, FL, to discuss the implications of the Cochrane Library's spinal cord stimulation review and what it means for providers and patients. Additionally, David Caraway, MD, PhD, Chief Medical Officer of Nevro Corp., calls in to give his expert insight on the controversial inclusion and exclusion of certain studies and how this impacts the conclusions of the review. Lastly, we go to Vwaire Orhurhu MD, MPH, author of a widely-read letter to the editor published in JAMA in response to the Hara et al. study, which is critical to the Cochrane Library Review's conclusions.Tune in to discover:In-depth scientific analysis and reaction to the curious findings, generalizations, and omissions from the reviewHow to interpret the Cochrane Library's recent findings and what they actually might mean for clinical practice. What this review means for patient care and the future of SCS in pain medicine Reference: Traeger AC, Gilbert SE, Harris IA, Maher CG. Spinal cord stimulation for low back pain. Cochrane Database of Systematic Reviews 2023, Issue 3. Art. No.: CD014789. DOI: 10.1002/14651858.CD014789.pub2. Accessed 29 March 2023.

Welcome to Teeth & Titanium Episode 30 - “Revisiting Bone Grafting Materials”   This episode features:   Current events -    Need to change the car? -    Courses and conferences with friends -    Oscar's Paternity leave challenge   Topic/Resident Reminder  -    Revisiting types of grafting materials for alveolar ridge preservation -    Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development   Journal Club -    Measuring Adherence to Antibiotic Use Guidelines in Managing Mandible Fractures -    Surprise cameos from popular guests   Recommendations -    A good walk spoiled -    A man and a young woman   Be sure to subscribe so you never miss an episode!   Apple / Spotify / Google / Online links   Thanks to the CAOMS for their continued support of this podcast. https://www.caoms.com   If you would like to contact us, be a guest, or would like to submit a topic for Resident Reminder or Journal club, please email us at: teethandtitaniumOMFS@gmail.com   Hosted by Dr. Wendall Mascarenhas and Dr. Oscar Dalmao Produced by Dr. Brad W. Ray   Article(s) cited in this episode:   Atieh MA, Alsabeeha NHM, Payne AGT, Ali S, Faggion CM Jr, Esposito M. Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD010176.   Beckstrom TO, Dodson TB, Lang MS. Measuring Adherence to Antibiotic Use Guidelines in Managing Mandible Fractures. J Oral Maxillofac Surg. 2023 Mar;81(3):287-291. doi: 10.1016/j.joms.2022.11.017. Epub 2022 Dec 26. PMID: 36581312.

Infant Vitamin D requirements of 400 IU are only being met a fraction of the time, as compliance postpartum remains an issue with this busy and challenging phase of life.  In this podcast, we discuss the most recent systematic review by Coresello (2022) discussing various Vitamin D supplementation strategies postpartum, and potential alternatives to infant dosing strategies. We take a deep dive into two of the studies discussed that provide different maternal Vitamin D dosing strategies, one that includes daily dosing (Hollis 2015) and the other that utilizes monthly dosing (Chandy 2016). We also discuss the Cochrane Review on this topic (Tan 2020) which covers their review of Vitamin D dosing in exclusively breastfed infants.    References:  Chandy, D. D., Kare, J., Singh, S. N., Agarwal, A., Das, V., Singh, U., Ramesh, V., & Bhatia, V. (2016). Effect of vitamin D supplementation, directly or via breast milk for term infants, on serum 25 hydroxyvitamin D and related biochemistry, and propensity to infection: A randomised placebo-controlled trial. The British Journal of Nutrition, 116(1), 52–58. https://doi.org/10.1017/S0007114516001756   Corsello, A., Milani, G. P., Giannì, M. L., Dipasquale, V., Romano, C., & Agostoni, C. (2022). Different Vitamin D Supplementation Strategies in the First Years of Life: A Systematic Review. Healthcare (Basel, Switzerland), 10(6), 1023. https://doi.org/10.3390/healthcare10061023   Hollis, B. W., Wagner, C. L., Howard, C. R., Ebeling, M., Shary, J. R., Smith, P. G., Taylor, S. N., Morella, K., Lawrence, R. A., & Hulsey, T. C. (2015). Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Pediatrics, 136(4), 625–634. https://doi.org/10.1542/peds.2015-1669 Tan, M. L., Abrams, S. A., & Osborn, D. A. (2020). Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health. The Cochrane Database of Systematic Reviews, 12(12), CD013046. https://doi.org/10.1002/14651858.CD013046.pub2

Gabapentin is the 10th most prescribed drug in the United States and use is increasing.  In 2002, 1% of adults were taking gabapentinoids (gabapentin and or pregabalin).  By 2015 that number increased to 4% of US adults. There are a lot of reasons that may explain the massive increase in use of these drugs.  One thing is clear, it is not because people are using it for FDA approved indications.  The FDA-approved indications for gabapentin are only for treating patients with partial seizures or postherpetic neuralgia. However, most gabapentin prescriptions are written off-label indications. On today's podcast we talk all about the Gabapentinoids - Gabapentin and Pregabalin - with Tasce Bongiovanni, Donovan Maust and Nisha Iyer.   It's a big episode covering a lot of topics. First, Nisha, a pain and palliative care pharmacist, starts us off with discussing the pharmacology of gabapentin and pregabalin, including common myths like they work on the GABA system (which is weird given the name of the drug).   Tasce, a surgeon and researcher, reviews the use of gabapentin in the perioperative setting and the research she had done on the prolonged use of newly prescribed gabapentin after surgery (More than one-fifth of older adults prescribed gabapentin postoperatively continue to take it more than 3 months later).  Donovan discusses the growth of “mood stabilizers/antiepileptics” (e.g. valproic acid and gabapentin), in nursing homes, particularly patients with Alzheimer's disease and related dementias. This includes a JAGS study recently published in 2022 showing that we seem to be substituting one bad drug (antipsychotics and opioids) with another bad drug (valproic acid and gabapentin). Lastly, we also addressed a big reason for the massive uptake of gabapentinoids: an intentional and illegal strategy by the makers of these drugs to promote off-label use by doing things like creating low-quality, industry-funded studies designed to exaggerate the perceived analgesic effects of these drug.  This long and sordid history of gabapentin and pregabalin is beautifully described in Seth Landefeld and Mike Steinman 2009 NEJM editorial. I could go on and on, but listen to the podcast instead and for a deeper dive, take a look at the following articles and studies: Gabapentin in the Perioperative setting: Prolonged use of newly prescribed gabapentin after surgery. J Am Geriatr Soc. 2022 Perioperative Gabapentin Use in Older AdultsRevisiting Multimodal Pain Management JAMA IM. 2022 Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort.  JAMA Surgery 2018 Gabapentin and mood stabilizers in the Nursing Home Setting: Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications. JAGS 2022 Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011-2014 JAMDA 2020 Efficacy of Gabapentinoids: Gabapentinoids for Pain: Potential Unintended Consequences. AFP 2019 Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews Review. 2017 The Illegal Marketing Practices by Pharma promoting ineffective: The Neurontin Legacy — Marketing through Misinformation and Manipulation NEJM 2009 Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Annals of IM. 2006  

Today, I am excited to share a replay of one of my favorite birth stories featured on the Evidence Based Birth® podcast. EBB childbirth class graduates, Brooklyn and Hoang Pham, share their power and miraculous birth story, which became an instant classic and truly touched my heart.   As a content warning, we talk about the significantly high rates of maternal mortality among Black and Brown individuals and racism in birth work.  On today's podcast, we will be talking with Brooklynn and Hoang Pham. Brooklynn and Hoang currently live in Davis, California, and are the parents to Marvel, who turned seven months last December. Brooklynn is the senior managing director of Teach For America in Sacramento, and Hoang is finishing up his final year of law school at UC Davis School of Law. They took the Evidence Based Birth® Childbirth class with EBB instructor, Shalin Butterworth, and are here to share their birth story. We will talk about Brooklynn's and Hoang's empowering experience when they attended the Evidence Based Birth® Childbirth class and how it prepared them to feel ready for their powerful and miraculous birth with their doula and EBB instructor, Shalin.  Resources:  Sign up for the EBB Newsletter here.  Learn more about the EBB Instructor program here and find an instructor or course here.  Hoang and Brooklyn's YouTube: https://www.youtube.com/channel/UCOBNp5cuEQpBDY3-3Bnl6eQ/ Instagram: @_hoangpham Twitter: @_hoangpham Birthplace Lab: You can explore the maps at https://www.birthplacelab.org/maps/. There is a How To video with tips on using the interactive maps: https://www.birthplacelab.org/how-to-explore-the-maps/. Visit BirthPlaceLab.org to learn about your state's score! Research References: Balde, M. D., Nasiri, K., Mehrtash, H., et al. (2020). Labour companionship and women's experiences of mistreatment during childbirth: results from a multi-country community-based survey. BMJ Glob Health. 2020 Nov;5(Suppl 2):e003564. Click here.   Bohren, M. A., Berger, B. O., Munthe-Kaas, H., et al. (2019). Perceptions and experiences of labour companionship: a qualitative evidence synthesis. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD012449. Click here.   Bohren, M. A., Hofmeyr, G. J., Sakala, C., et al. (2017). Continuous support for women during childbirth. Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD003766. Click here.   Vedam, S., Stoll, K., MacDorman, M., et al. (2018). Mapping integration of midwives across the United States: Impact on access, equity, and outcomes. PLoS One. 2018 Feb 21;13(2):e0192523. Click here. Go to our YouTube channel to see video versions of the episode listed above!! For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on:  TikTok Instagram Pinterest Ready to get involved?  Check out our Professional membership (including scholarship options) here  Find an EBB Instructor here  Click here to learn more about the Evidence Based Birth® Childbirth Class.

If you've followed me on instagram for a while, or you've engaged in any of my courses, you know i'm super passionate about creating environments that support physiological birth. This episode let's you in on 5 things that can influence your birth as well as the evidence to support them. Below are the key references I mention if you feel like digging a little deeper! Lawrence A, Lewis L, Hofmeyr GJ, Dowswell T, Styles C. Maternal positions and mobility during first stage labour. Cochrane Database of Systematic Reviews 2009, Issue 2. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003934.pub2/full/es# Cluett ER, Burns E, Cuthbert A. Immersion in water during labour and birth. Cochrane Database of Systematic Reviews 2018, Issue 5. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000111.pub4/full?contentLanguage=en Wrønding T, Argyraki A, Petersen JF, Topsøe MF, Petersen PM, Løkkegaard ECL. The aesthetic nature of the birthing room environment may alter the need for obstetrical interventions - an observational retrospective cohort study. Sci Rep. 2019;9(1):303. Keen for more? Follow @birthwithbeth_ on instagram for education, updates and insights. Consider it midwifery with a side of motherhood.

Survey: https://bit.ly/feedback_UltraSounds Theresa and Rachel discuss postpartum hemorrhage with Dr. Luke Burns. 00:30 Dr. Burns Biography 01:50 Case 1: 35 year old G4P4 with polyhydramnios, boggy uterus 09:17 Case 2: 35 year old G4P4 with postpartum hemorrhage and chronic hypertension 16:53 Case 3: hemodynamically unstable 35 year old G4P4 with postpartum hemorrhage 23:59 Case 4: 35 year old G4P4 with no return of menstruation Transcript: https://bit.ly/Ultrasounds_PPH Trends in maternal mortality: 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019. ACOG Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol 2017, 30(4). Wormer KC, Jamil RT, Bryant SB. Acute Postpartum Hemorrhage. StatPearls Publishing; 2022 Jan. ACOG Committee Opinion No. 794: Quantitative blood loss in obstetric hemorrhage. American College of Obstetricians and Gynecologists. Obstet Gynecol 2019;134. Bell, S. F., et al (2020). Incidence of postpartum haemorrhage defined by quantitative blood loss measurement: a national cohort. BMC pregnancy and childbirth, 20(1), 271. Parry Smith WR, et al. Uterotonic agents for first‐line treatment of postpartum haemorrhage: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 11. Vogel JP, et al. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? BMJ Global Health 2019. A. Borovac-Pinheiro, et al. (2018). Postpartum hemorrhage: new insights for definition and diagnosis. American Journal of Obstetrics and Gynecology, 219(2):162-8. A. Leleu, et al. (2021). Intrauterine balloon tamponade in the management of severe postpartum haemorrhage after vaginal delivery: Is the failure early predictable?. European Journal of Obstetrics & Gynecology and Reproductive Biology, 258:317-323. Schury MP, Adigun R. Sheehan Syndrome. StatPearls Publishing; 2022 Jan.

EBB 244: Evidence on Artificial Rupture of Membranes, Assisted Vaginal Delivery, and Internal Monitoring.   We are so excited to announce the upcoming release of a new Evidence Based Birth(R) Pocket Guide, all about Interventions! To give you a sneak peek to the Invention Pocket Guide,  we are diving into the research and evidence on artificial rupture of membranes, assisted vaginal delivery an internal monitoring.   Content note: Discussion of the benefits and risks of these interventions, including forceps and vacuum-assisted deliveries, which can be associated with birthing trauma for birthing people and babies, as well as the risk of mortality. Resources: Make sure you're on the Pocket Guide wait list by going here  Amniotomy References: Kawakita, T., Huang, C-C, and Landy, H. J. (2018). Risk Factors for Umbilical Cord Prolapse at the Time of Artificial Rupture of Membranes. AJP Rep 8(2): e89-e94. https://pubmed.ncbi.nlm.nih.gov/29755833/ Simpson, K. R. (2020). Cervical Ripening and Labor Induction and Augmentation, 5th Edition. AWHONN Practice Monograph 24(4): PS1-S41. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-019-2491-4 Smyth, R. M., Markham, C. & Dowswell, T. (2013). Amniotomy for shortening spontaneous labour. Cochrane Database Syst Rev 6:CD006167. https://pubmed.ncbi.nlm.nih.gov/23780653/ Alfirevic, Z., Keeney, E., Dowswell, T., et al. (2016). Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG 123(9):  1462-1470. https://pubmed.ncbi.nlm.nih.gov/27001034/  de Vaan, M. D. T., ten Eikelder, M. L. G., Jozwiak, M., et al. (2019). Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews 10: CD001233. https://www.cochrane.org/CD001233/PREG_mechanical-methods-induction-labour Simpson, K. R. (2020). Cervical Ripening and Labor Induction and Augmentation, 5th Edition. AWHONN Practice Monograph, 24(4), PS1-S41. https://nwhjournal.org/article/S1751-4851(20)30079-9/abstract   Assisted Vaginal Delivery References: NHS article on forceps or vacuum delivery https://www.nhs.uk/pregnancy/labour-and-birth/what-happens/forceps-or-vacuum-delivery/ Bailey, P. E., van Roosmalen, J., Mola, G., et al. (2017). Assisted vaginal delivery in low and middle income countries: an overview. BJOG 124(9): 1335-1344. https://pubmed.ncbi.nlm.nih.gov/28139878/ CDC Wonder Database Feeley, C., Crossland, N., Betran, A. P., et al. (2021). Training and expertise in undertaking assisted vaginal delivery (AVD): a mixed methods systematic review of practitioners views and experiences. Reprod Health 18(1): 92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097768/ Crossland, N., Kingdon, C., Balaam, M. C. (2020). Women's, partners' and health care providers' views and experiences of assisted vaginal birth: a systematic mixed methods review. Reprod Health 17:83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268509/ Hook, C. D., Damos, J. R. (2008). Vacuum-Assisted Vaginal Delivery. Am Fam Physician 78(8): 953-960. https://www.aafp.org/afp/2008/1015/p953.html Tsakiridis, I., Giouleka, S., Mamopoulos, A., et al. (2020). Operative vaginal delivery: a review of four national guidelines. J Perinat Med 48(3): 189-198. https://pubmed.ncbi.nlm.nih.gov/31926101/ Verma, G. L., Spalding, J. J., Wilkinson, M. D., et al. (2021). Instruments for assisted vaginal birth. Cochrane Database Syst Rev. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005455.pub3/full   Internal Monitoring References: Euliano, T. Y., Darmanjian, S., Nguyen, M. T., et al. (2017). Monitoring fetal heart rate during labor: A comparison of three methods. J Pregnancy 2017: 8529816. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368359/ Neilson, J. P. (2015). Fetal electrocardiogram (ECG) for fetal monitoring during labor. Cochrane Database Syst Rev 12: CD000116. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000116.pub5/full Harper, L. M., Shanks, A. L., Tuuli, M. G., et al. (2013). The risks and benefits of internal monitors in laboring patients. Am J Obstet Gynecol 209(1): 38.e1-38.e6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760973/ Bakker, J. J. H., Verhoeven, C. J. M., Janssen, P. F., et al. (2010). Outcomes after internal versus external tocodynamometry for monitoring labor. N Engl J Med 362(4): 306-13. https://www.nejm.org/doi/10.1056/NEJMoa0902748?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov Frolova, A. I., Stout, M. J., Carter, E. B., et al. (2021). Internal fetal and uterine monitoring in obese patients and maternal obstetrical outcomes. Am J Obstet Gynecol MFM 3(1): 100282. https://pubmed.ncbi.nlm.nih.gov/33451595/ Bakker, J. J. H., Janssen, P. F., van Halem, K. (2013). Internal versus external tocodynamometry during induced or augmented labor. Cochrane Database Syst Rev 8: CD006947. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006947.pub3/full van Halem, K., Bakker, J. J. H., VerHoeven, C. J., et al. (2011). Does use of an intrauterine catheter during labor increase risk of infection? J Maternal Fetal Neonatal Med 25(4): 415-418. https://www.tandfonline.com/doi/abs/10.3109/14767058.2011.582905 For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on:  TikTok Instagram  Pinterest   Ready to get involved?  Check out our Professional membership (including scholarship options) here  Find an EBB Instructor here  Click here to learn more about the Evidence Based Birth® Childbirth Class.

Take a look in the mirror! Have you ever used mirror box therapy to help restore normal movement patterns? Join us where we reunite with Miranda Materi OTD, OTR/L, CHT from Phoenix, AZ discuss how Mirror Box Therapy can help with many different diagnoses from amputations to CRPS and even just stiffness. Miranda dives into how Mirror Box Therapy can be built at home in a “do it yourself” fashion or references where to buy a Mirror Box Kit. Please refer below for newer research articles found to support use of Mirror Box Therapy with your hand patients! CRPS and Mirror Box G. Lorimer Moseley, Alberto Gallace, Charles Spence, Is mirror therapy all it is cracked up to be? Current evidence and future directions, PAIN,Volume 138, Issue 1,2008,Pages 7-10, ISSN 0304-3959 https://doi.org/10.1016/j.pain.2008.06.026. (https://www.sciencedirect.com/science/article/pii/S0304395908003710) Amputees and Mirror Box Timms, Jason, and Catherine Carus. "Mirror therapy for the alleviation of phantom limb pain following amputation: A literature review." International Journal of Therapy and Rehabilitation 22.3 (2015): 135-145. Stroke and Mirror Box Thieme H, Morkisch N, Mehrholz J, Pohl M, Behrens J, Borgetto B, Dohle C. Mirror therapy for improving motor function after stroke. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD008449. DOI: 10.1002/14651858.CD008449.pub3. Accessed 05 October 2022. Hand Trauma and Mirror Box Grünert-Plüss, Nicole, et al. "Mirror therapy in hand rehabilitation: a review of the literature, the St Gallen protocol for mirror therapy and evaluation of a case series of 52 patients." The British Journal of Hand Therapy 13.1 (2008): 4-11.

In episode 9 we discuss psilocybin for treating alcohol use disorder.Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(10):953–962. doi:10.1001/jamapsychiatry.2022.2096----------We talk about Wal-Mart and CVS not filling some telemedicine prescriptions. We also discuss gabapentin involvement in overdose deaths and the efficacy of gabapentin for neuropathic pain.Mattson CL, Chowdhury F, Gilson TP. Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths — 23 States and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep 2022;71:664–666Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA. Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD007938. DOI: 10.1002/14651858.CD007938.pub4. Accessed 21 October 2022----------This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation, and we want to hear what you have to say. To have your opinions about the articles included in a future episode, send us your comments on Twitter or email, or join our Facebook group to continue the discussion.Email: addictionmedicinejournalclub@gmail.com Twitter: @AddictionMedJC Facebook: @AddictionMedJCCredits:Original theme music: composed and performed by Benjamin KennedyAudio production: Angela OhlfestAddiction Medicine Journal Club is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Are benzos effective for treating anxiety? Insomnia? Seizures? If they aren't safe, what is the evidence? How many BIND symptoms are there? Could these be permanent? And what about COVID? Tune in for the surprising answers.In today's episode, we ask some key questions about benzos and provide real answers, with evidence to back them. We also share questions from our international listeners on CBD and probiotics, and we hear a powerful story of one woman's struggle with her third attempt at withdrawal. This one if chock full of information, and I hope you'll join us.https://www.easinganxiety.com/post/the-facts-what-do-we-really-know-about-benzos-and-bind-bfp107Video ID: BFP107Chapters 0:00:00 INTRODUCTION0:01:16 About the Last Episode0:02:17 Behind the Scenes Work0:03:18 Hurricane Ian0:05:38 MAILBAG0:05:54 Benzo Belly and Probiotics (Jon)0:11:48 CBD and Withdrawal (Julie)0:17:29 BENZO STORY (Jessica)0:26:48 Response from D0:31:20 FEATURE: Benzo Facts0:32:48 Are Benzos Effective?0:35:23 Are Benzos Safe?0:43:49 Can You Be Addicted to Benzos?0:44:46 Is BIND an Official Term?0:47:21 How Many BIND Symptoms Are There?0:52:05 Is BIND Permanent?0:56:42 Are Z-drugs the Same as Benzos?0:57:22 Do Benzos Have an Effect on COVID?1:00:58 MOMENT OF PEACE Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Easing Anxiety of the resource or any recommendations or advice provided therein.SITE RESOURCES— Benzodiazepine Action Work Group (BAWG) — https://benzoaction.org— Benzodiazepine Information Coalition (BIC) — https://benzoinfo.com— The Alliance for Benzodiazepine Best Practices — https://benzoreform.org— Blazing Benzos Facebook Group — https://m.facebook.com/groups/1205287192817668/MAILBAGGrinspoon, Peter. Cannabidiol (CBD): What we know and what we don't. Harvard Health Publishing. September 24, 2021. Accessed September 27, 2022. https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476. FEATUREAshton, C. Heather. Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual). 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual. Ashton, C. Heather. Benzodiazepines: The Still Unfinished Story. (Speech at Beat the Benzos Launch Conference, Croyden, London, England). https://www.benzo.org.uk/ashspeech.htm. Bachhuber, Marcus A., Sean Hennessy, Chinazo O. Cunningham and Joanna L. Starrels. “Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.” American Journal of Public Health (AJPH) (April 2016). Accessed April 7, 2018. doi:10.2105/AJPH.2016.303061. Benzodiazepine Information Coalition (BIC). Withdrawal & Post Withdrawal Symptoms. Accessed September 29, 2022. https://www.benzoinfo.com/benzodiazepine-withdrawal-post-withdrawal-symptoms/. Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJC, Furukawa TA, Koesters M. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD010677. DOI: 10.1002/14651858.CD010677.pub2. Accessed 27 September 2022. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010677.pub2/full. Commonwealth of Pennsylvania. Prescribing Guidelines for Pennsylvania: Safe Prescribing Benzodiazepines for Acute Treatment of Anxiety & Insomnia. Updated May 15, 2017. Accessed April 7, 2018. http://www.health.pa.gov/My%20Health/Diseases%20and%20Conditions/M-P/opioids/Documents/PA%20Guidelines%20on%20Benzo%20Prescribing.pdf. Easing Anxiety. BIND Symptoms. https://easinganxiety.com/symptoms. Foster, D E. Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal. Erie, CO: Denim Mountain Press, 2018. https://easinganxiety.com/book. Frances, Allen. Yes, Benzos Are Bad for You. Pro Talk: A Rehabs.com Community. June 10, 2016. Accessed October 13, 2016. https://www.rehabs.com/pro-talk-articles/yes-benzos-are-bad-for-you/. Guina J, Merrill B. Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. J Clin Med. 2018 Jan 30;7(2):17. doi: 10.3390/jcm7020017. PMID: 29385731; PMCID: PMC5852433. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852433/. Kripke, D. F., R.D. Langer and L.E. Kline. Hypnotics' Association with Mortality or Cancer: A Matched Cohort Study. BMJ Open 2(e000850)(2012). Accessed June 21, 2017. doi:10.1136/bmjopen-2012-000850. Lakhani, Nina, Drugs Linked to Brain Damage 30 Years Ago, Independent, November 7, 2010, accessed March 4, 2017, https://www.independent.co.uk/life-style/health-and-families/health-news/drugs-linked-to-brain-damage-30-years-ago-2127504.html. New York City Department of Health and Mental Hygiene (NYC DOHMH). City Health Information: Judicious Prescribing of Benzodiazepines. 35(2)(2016). https://docs.wixstatic.com/ugd/990dad_167113513c9445f8bc77a77370ce649f.pdf. Park, H.Y., Kwon, J., An, S.K. et al. A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes. Sci Rep 12, 15947 (2022). https://doi.org/10.1038/s41598-022-20335-z. U.S. Drug Enforcement Agency (DEA). Office of Diversion Control; Drug & Chemical Evaluation Section: Benzodiazepines (January 2013). Accessed March 6, 2017. https://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf. U.S. Food & Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. September 23, 2020. Accessed September 27, 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class.  The PodcastThe Benzo Free Podcast provides information, support, and community to those who struggle with the long-term effects of anxiety medications such as benzodiazepines (Xanax, Ativan, Klonopin, Valium) and Z-drugs (Ambien, Lunesta, Sonata). WEBSITE: https://www.easinganxiety.comMAILING LIST: https://www.easinganxiety.com/subscribe YOUTUBE: https://www.youtube.com/@easinganx DISCLAIMERAll content provided by Easing Anxiety is for general informational purposes only and should never be considered medical advice. Any health-related information provided is not a substitute for medical advice and should not be used to diagnose or treat health problems, or to prescribe any medical devices or other remedies. Never disregard medical advice or delay in seeking it. Please visit our website for our complete disclaimer at https://www.easinganxiety.com/disclaimer. CREDITSMusic provided / licensed by Storyblocks Audio — https://www.storyblocks.com Benzo Free Theme — Title: “Walk in the Park” — Artist: Neil Cross PRODUCTIONEasing Anxiety is produced by… Denim Mountain Presshttps://www.denimmountainpress.com ©2022 Denim Mountain Press – All Rights Reserved

Share this post with others: Are benzos effective for treating anxiety? Insomnia? Seizures? If they aren't safe, what is the evidence? How many BIND symptoms are there? Could these be permanent? And what about COVID? Tune in for the surprising answers. In today's episode, we ask some key questions about benzos and provide real answers, with evidence to back them. We also share questions from our international listeners on CBD and probiotics, and we hear a powerful story of one woman's struggle with her third attempt at withdrawal. This one if chock full of information, and I hope you'll join us. Welcome to Episode #107 Today, we use our standard format to answer a couple of questions from our listeners, share an emotional benzo story, and answer several questions about benzos, withdrawal, and BIND. This episode is full of useful information and references and I hope you enjoy it. Video ID: BFP107 Chapters 0:00:00  INTRODUCTION0:01:16  About the Last Episode0:02:17  Behind the Scenes Work0:03:18  Hurricane Ian0:05:38  MAILBAG0:05:54  Benzo Belly and Probiotics (Jon)0:11:48  CBD and Withdrawal (Julie)0:17:29  BENZO STORY (Jessica)0:26:48  Response from D0:31:20  FEATURE: Benzo Facts0:32:48  Are Benzos Effective?0:35:23  Are Benzos Safe?0:43:49  Can You Be Addicted to Benzos?0:44:46  Is BIND an Official Term?0:47:21  How Many BIND Symptoms Are There?0:52:05  Is BIND Permanent?0:56:42  Are Z-drugs the Same as Benzos?0:57:22  Do Benzos Have an Effect on COVID?1:00:58  MOMENT OF PEACE Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Benzo Free of the resource or any recommendations or advice provided therein. — Benzodiazepine Action Work Group (BAWG) — https://benzoaction.org— Benzodiazepine Information Coalition (BIC) — https://benzoinfo.com— The Alliance for Benzodiazepine Best Practices — https://benzoreform.org— Blazing Benzos Facebook Group — https://m.facebook.com/groups/1205287192817668/ References MAILBAG Grinspoon, Peter. Cannabidiol (CBD): What we know and what we don't. Harvard Health Publishing. September 24, 2021. Accessed September 27, 2022. https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476. FEATURE Ashton, C. Heather. Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual). 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.Ashton, C. Heather. Benzodiazepines: The Still Unfinished Story. (Speech at Beat the Benzos Launch Conference, Croyden, London, England). https://www.benzo.org.uk/ashspeech.htm.Bachhuber, Marcus A., Sean Hennessy, Chinazo O. Cunningham and Joanna L. Starrels. "Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013." American Journal of Public Health (AJPH) (April 2016). Accessed April 7, 2018. doi:10.2105/AJPH.2016.303061.Benzodiazepine Information Coalition (BIC). Withdrawal & Post Withdrawal Symptoms. Accessed September 29, 2022. https://www.benzoinfo.com/benzodiazepine-withdrawal-post-withdrawal-symptoms/.Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJC, Furukawa TA, Koesters M. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD010677. DOI: 10.1002/14651858.CD010677.pub2. Accessed 27 September 2022. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010677.pub2/full.Commonwealth of Pennsylvania. Prescribing Guidelines for Pennsylvania: Safe Prescribing Benzodiazepines for Acute Treatment of Anxiety & Insomnia. Updated May 15, 2017. Accessed April 7, 2018. http://www.health.pa.gov/My%20Health/Diseases%20and%20Conditions/M-P/opioids/Documents/PA%20Guidelines%20on%20Benzo%20Prescribing.pdf.Easing Anxiety. BIND Symptoms. https://easinganxiety.com/blog/bind-symptoms/.Foster, D E.

Join Tim and Kim as they talk  with Dr. Hsin Huang, Secretary General of the International Meat Secretariat about some of the surprising products that come from cows other than milk and meat.  CitationsAlam, A. Y. (n.d.). The challenge of dealing with animal derived ingredients in medical/surgical products. 3.Alao, B., Falowo, A., Chulayo, A., & Muchenje, V. (2017). The Potential of Animal By-Products in Food Systems: Production, Prospects and Challenges. Sustainability, 9(7), 1089. https://doi.org/10.3390/su9071089Jayathilakan, K., Sultana, K., Radhakrishna, K., & Bawa, A. S. (2012). Utilization of byproducts and waste materials from meat, poultry and fish processing industries: A review. Journal of Food Science and Technology, 49(3), 278–293. https://doi.org/10.1007/s13197-011-0290-7Khouw, B. T., Rubin, L. J., & Berry, B. (n.d.). Meat Animal By-Products of Pharmaceutical and Food Interest. 8.Quin, J. (2020). Medicines/pharmaceuticals of animal origin. 33.Singh, N., Halliday, H. L., Stevens, T. P., Suresh, G., Soll, R., & Rojas-Reyes, M. X. (2015). Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD010249.pub2Toldrá, F., Reig, M., & Mora, L. (2021). Management of meat by- and co-products for an improved meat processing sustainability. Meat Science, 181, 108608. https://doi.org/10.1016/j.meatsci.2021.108608

In this week's slightly longer episode, SPA's Anneke Flinn speaks with Dr Kieran Flanagan, Senior Lecturer and Course Coordinator of Speech Pathology at Australian Catholic University in Queensland. Kieran explores three current research papers in the area of Childhood Apraxia of Speech: Murray, E., Iuzzini-Seigel, J., Maas, E., Terband, H., & Ballard, K. J. (2021). Differential diagnosis of childhood apraxia of speech compared to other speech sound disorders: A systematic review [Review]. American Journal of Speech-Language Pathology, 30(1), 279-300. Morgan, A. T., Murray, E., & Liégeois, F. J. (2018). Interventions for childhood apraxia of speech [Review]. Cochrane Database of Systematic Reviews, 2018(5), Article Cd006278. This paper can be accessed by following this link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/full Strand, E. A. (2020). Dynamic temporal and tactile cueing: A treatment strategy for childhood apraxia of speech. American Journal of Speech-Language Pathology, 29(1), 30-48. Please email Anneke at speakuppodcast@speechpathologyaustralia.org.au if you would like a list of references mentioned in this episode. Speech Pathology Australia acknowledges the Traditional Custodians of lands, seas and waters throughout Australia, and pay respect to Elders past, present and future. We recognise that the health and social and emotional wellbeing of Aboriginal and Torres Strait Islander peoples are grounded in continued connection to culture, country, language and community, and acknowledge that sovereignty was never ceded.

Perhaps the cutest of the ages, the “almost grown enough to skip the NICU” moderate preterm babies are the topic this week. These babies are 32 and 0/7-weeks to 33 and 6/7-weeks but the discussion extends to the late pretermers who find themselves in a NICU. There has been so much research in the last few years about these babies and the things that impact them both short and long term! Join us as we discuss:Cue based feeding in the moderate/late pretermBetamethasone and Magnesium sulfate in this group and how it impacts infants at deliveryWhat it means to support an infant's natural ability vs impose medical standards Early neonatal research (the name wouldn't come during our recording but, if you want to know, it was Dr. Edgar Rey Sanabria in 1978)As if all of that wasn't fun enough…we also talk about jaundice, the plague…and zombies?!?! Honestly, we haven't laughed that hard in a long time! We hope you will laugh along with us. If our suspicions are correct, this won't be the last time this comes up!Bibliography:Bulut,  A., Cundubey, C., Ceyhan, V., & Aydin, E. (2022). Comparison of neonatal  outcomes with and without the administration of betamethasone in late preterm  births. International Journal of Gynecology and Obstetrics, 349-354.  doi:10.1002/ijgo.14028Chollat, C.,  Sentilhes, L., & Marret, S. (2018). Fetal neuroprotection by magnesium  sulfate: from translational research to clinical application. Frontiers in  Neurology, 247.Conde-Agudelo,  A., & Diaz-Rossello, J. (2016). Kangaroo mother care to reduce morbidity  and mortality in low birth weight infants. Cochrane Database of Systematic  Reviews(8), Art. No.: CD002771. doi:10.1002/14651858.CD002771.pub4Kamran, F.,  Khatoonabadi, A. R., Aghajanzadeh, M., Ebadi, A., Faryadras, Y., & Sagheb,  S. (2020). Effectiveness of cue-based feeding versus scheduled feeding in  preterm infants using comprehensive feeding assessment scales: a randomized  clinical trial. Iran Journal of Pediatrics, :e107475.  doi:10.5812/ijp.107475.Woythaler MS, DO,  M. (2019). Neurodevelopmental outcomes of the late preterm infant. Seminars  in Fetal and Neonatal Medicine, 54-59. doi:10.1016/j.siny.2018.10.002Notes:EDC – Estimated date of confinement, also call the estimated  date of delivery (EDD) or the due date. This uses the date of the last  menstrual period to estimate the date of a 40-week, full term delivery. The calculation  is based on Naegele's rule. If you want a  cheat try this calculator.  Gestational Age – The number of completed weeks of a  pregnancy at the time of delivery. Clinically, the gestational age assessment  is based on the EDC, fetal ultrasound measurements, and gestational age  scoring done at delivery. Check out this Get Your Pens for an in-depth look

A randomized controlled trial is viewed as the golden standard in medical research, particularly as it relates to treatments or interventions. But there may be pitfalls to trusting that approach too much. That's the focus of this episode of Stats and Stories with guest Erik van Zwet. -Timestamps- What is a RCT? (1:15), What are characteristic of a well designed trial? (2:00), How did you get interested in this research?(3:45), Data you obtained from Cochrane Database? 5:18), Power and how you got results (7:05), How does affect the laymen (9:49), Coverage of RCTs (12:00), Trends of exaggeration (14:17), What goes into exaggeration? (16:54), What needs to be done? (18:56), Across other fields (21:58) Erik van Zwet (@erikvanzwet) is an Associate Professor in the Department of Biomedical Data Sciences of the Leiden University Medical Center where he has been since 2009. He joined the school wanting to do more applied work in the areas of statistics and data analysis and has since published multiple papers in Significance Magazine including the main focus of today's episode, “Addressing exaggeration of effects from single RCTs”.

We've already covered a couple of episodes on sleep, including the https://yourparentingmojo.com/captivate-podcast/sleep/ (cultural issues associated with sleep), then more recently we talked with https://yourparentingmojo.com/captivate-podcast/restedchild (Dr. Chris Winter about his book The Rested Child) where we looked at sleep issues in older children.   But if you have a young child who isn't sleeping well, from the baby stage all the way up to about preschool, this episode is for you!  My guest is Macall Gordon, senior lecturer in the Department of Psychology at Antioch University Seattle, and who has studied young children's sleep for 20 years.  She's particularly interested in the intersection between children's temperament and their sleep, and how parents of the children she calls 'little livewires' can support these children so everyone gets more sleep.   If you have questions about sleep training - particularly when and how to do it - this episode is for you!   And if you're expecting a baby or have one under the age of one (whether this is your first or not!) you might be interested in the Right From The Start course, which is designed to help you get things right for you from the start.  We go in-depth on understanding topics like sleep, feeding, physical, mental, and emotional development, and more - both for baby and for you!   Get all the (research-backed, of course) information you need, plus a supportive community and four group coaching calls during the 8-week course.  Enrollment is open from April 3-13, and we start together on Monday April 18.  Click the picture below to learn more!     References: Macall Gordon's website, https://www.littlelivewires.com/ (Little Livewires) Adachi, Y., Sato, C., Nishino, N., Ohryoji, F., Hayama, J., & Yamagami, T. (2009). A brief parental education for shaping sleep habits in 4-month- old infants. Clinical Medicine & Research, 7(3), 85–92. Blunden, S., & Baills, A. (2013). Treatment of behavioural sleep problems: Asking the parents. Journal of Sleep Disorders: Treatment and Care, 2(2). Blunden, S., Etherton, H., & Hauck, Y. (2016). Resistance to cry intensive sleep intervention in young children: Are we ignoring children's cries or parental concerns? Children, 3(2), 8. Bryanton, J., & Beck, C. T. (2010). Postnatal parental education for optimizing infant general health and parentinfant relationships. Cochrane Database of Systematic Reviews, 1, CD004068. Byars, K. C., & Simon, S. L. (2016). Behavioral treatment of pediatric sleep disturbance: Ethical considerations for pediatric psychology practice. Clinical Practice in Pediatric Psychology, 4(2), 241. Byars, K. C., Yolton, K., Rausch, J., Lanphear, B., & Beebe, D. W. (2012). Prevalence, patterns, and persistence of sleep problems in the first 3 years of life. Pediatrics, 29(2). Chadez, L. H., & Nurius, P. S. (1987). Stopping bedtime crying: Treating the child and the parents. Journal of Clinical Child Psychology, 16(3), 212–217. Coe, C. L., Glass, J. C., Wiener, S. G., & Levine, S. (1983).Behavioral, but not physiological, adaptation to repeated separation in mother and infant primates. Psychoneuroendocrinology, 8(4), 401-409. Crichton, G. E., & Symon, B. (2016). Behavioral management ofsleep problems in infants under 6 months- -What works? Journal of Developmental and Behavioral Pediatrics, 37(2), 164–171. Cutrona, C. E., & Troutman, B. R. (1986). Social support, infant temperament, and parenting self-efficacy: A mediational model of postpartum depression. Child Development, 1507-1518. Didden, R., De Moor, J., & Kruit, I. W. (1999). The effects of extinction in the treatment of sleep problems with a child with a physical disability. International Journal of Disability, Development and Education, 46(2), 247–252. Douglas, P. S., & Hill, P. S. (2013). Behavioral sleep...

I dive deep into four general categories of medications that are often prescribed for people living with dementia: antidepressants, mood stabilizers, benzodiazepines (spoiler alert--not a good option), and antipsychotics. Learn why these medications are prescribed and what problems may happen when your family member takes them. This information is for educational use only. Consult your healthcare professional before making any medication changes. I hope that this information assists you with having conversations about medications with your healthcare provider. Here are the studies I mention: Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database of Systematic Reviews. 2011(2). McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016;11:CD009178. Baillon SF, Narayana U, Luxenberg JS, Clifton AV. Valproate preparations for agitation in dementia. Cochrane Database Syst Rev. 2018;10:CD003945. PODCAST CHALLENGE! · Rate and review my podcast on your favorite platform · E-mail me a screenshot before Friday, March 11 at 5 pm central time US; if you want to game the system and rate and review on multiple platforms, go for it! Email: rita.jablonski@gmail.com · 3 winners will receive a signed, autographed copy of my book · Winners will be announced during Episode 37 (which will be dropped Sunday, March 13 2022) CHECK OUT MY BOOK! “Make Dementia Your B*tch! An Easy Guide to Understanding and Handling Dementia-driven Behaviors.” Have a dementia question? Want to hear it answered on a future podcast? Email me: rita.jablonski@gmail.com. Are you a visual learning? Check out my YouTube channel, where I demonstrate strategies like bridging and chaining Looking for a community? I have my own Facebook page for dementia caregivers: Make Dementia Your B! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/rita-a-jablonski/message

Resources:Answer the Public- https://answerthepublic.com/reports/78271ee8-c4c4-4bd4-877d-8c5c5295faac MT-BC Directory- https://netforum.avectra.com/eweb/DynamicPage.aspx?Site=AMTA2&WebCode=IndSearch MT-BC Certification: https://www.cbmt.org/candidates/certification/ History of Music Therapy: https://www.musictherapy.org/about/history/ Bonus Articles: “Music Therapy in the Treatment of Dementia”- Moreno-Morales, C., Calero, R., Moreno-Morales, P., & Pintado, C. (2020). Music Therapy in the Treatment of Dementia: A Systematic Review and Meta-Analysis. Frontiers in medicine, 7, 160. https://doi.org/10.3389/fmed.2020.00160 “Music Therapy for People with Autism Spectrum Disorder” - Geretsegger M, Elefant C, Mössler KA, Gold C. Music therapy for people with autism spectrum disorder. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD004381. DOI: 10.1002/14651858.CD004381.pub3. Accessed 03 September 2021.Thank you for listening. We appreciate your feedback, please rate and review wherever you listen. If you like the show, please subscribe and share with a friend! ——— Stay in touch at https://www.musictherapyandbeyond.comFollow us on Instagram @musictherapyandbeyond Follow us on Facebook at https://www.facebook.com/musictherapyandbeyond

Worldwide, Alcohol Use Disorder kills 3.3 million people every year. It is the leading cause of death in working men around the world. Alcohol problems are responsible for 10 times the number of fatalities from all illicit drugs combined. Dr. John F. Kelly is a Professor of Psychiatry in Addiction Medicine at Harvard Medical School and Founder and Director of the Recovery Research Institute at the Massachusetts General Hospital (MGH). Dr. Kelly led the most rigorous scientific review of Alcoholics Anonymous performed to date. This review, published in the Cochrane Database of Systematic Reviews, is based on 27 rigorous studies (21 RCT's) done over the past 25 years, involving over 10,000 participants, 150 scientists and 67 institutions. The review reveals that AA and Twelve Step Facilitation not only perform as well as other interventions like CBT and Motivational Enhancement Therapy (MET), but actually do better at helping many more people achieve sustained continuous abstinence and remission. AA and Twelve Step Facilitation produce increased rates and lengths of abstinence when compared to other common treatments. Dr. Kelly shares the research behind why AA is so successful and how AA tends to benefit men and women differently. He draws from decades of scientific research to address the following questions: On average, how long does it take to achieve one year of continuous sobriety? How long does it take to rewire the brain during abstinence, thereby reducing the risk of Alcohol Use Disorder to that of the general population? When talking to a person with Alcohol Use Disorder in early sobriety, how would you explain the changes in his brain? Dr. Kelly offers hope as he comments on the percentage of people with Alcohol Use Disorder who actually achieve full sustained remission. Dr. Kelly normalizes ambivalence and explains how Motivational Interviewing can help move a person toward readiness to change. He shares the 5 most important factors that predict successful long term recovery. Dr. Kelly speaks to the suffering of family members and offers helpful suggestions. We discuss collegiate recovery programs and other sober support networks, like Smart Recovery. You won't want to miss an hour with brilliant Dr. John F Kelly, a man who has dedicated his entire career to scientific research aimed at helping people affected by Alcohol Use Disorder and their families fully recover and reclaim their lives.